BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells. Cell 1998;93:705-16. [DOI: 10.1016/s0092-8674(00)81433-6] [Cited by in Crossref: 1584] [Cited by in F6Publishing: 1486] [Article Influence: 66.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis. Antioxidants (Basel) 2022;11:1195. [PMID: 35740092 DOI: 10.3390/antiox11061195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Montecillo-aguado M, Tirado-rodriguez B, Antonio-andres G, Morales-martinez M, Tong Z, Yang J, Hammock BD, Hernandez-pando R, Huerta-yepez S. Omega-6 Polyunsaturated Fatty Acids Enhance Tumor Aggressiveness in Experimental Lung Cancer Model: Important Role of Oxylipins. IJMS 2022;23:6179. [DOI: 10.3390/ijms23116179] [Reference Citation Analysis]
3 Benoit L, Jornod F, Zgheib E, Tomkiewicz C, Koual M, Coustillet T, Barouki R, Audouze K, Vinken M, Coumoul X. Adverse outcome pathway from activation of the AhR to breast cancer-related death. Environ Int 2022;165:107323. [PMID: 35660951 DOI: 10.1016/j.envint.2022.107323] [Reference Citation Analysis]
4 Pan Y, Cao S, Tang J, Arroyo JP, Terker AS, Wang Y, Niu A, Fan X, Wang S, Zhang Y, Jiang M, Wasserman DH, Zhang M, Harris RC. Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice. Journal of Clinical Investigation 2022;132:e152391. [DOI: 10.1172/jci152391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang C, Guan X, Song Z, Jiang H, Liu Y, Chen P, Duan J, Zhou Y, Poggi A. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells via Nrf2-Mediated Inhibition of TGF-β1/Smad Signaling. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/5759626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guangshun S, Guoqiang S, Xin C, Xiangyi K, Wubin Z, Zhitao L, Zhiying Z, Hongyong C, Chengyu L, Yongxiang X, Weiwei T, Kanjoormana Aryan M. Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4598573] [Reference Citation Analysis]
7 Zhang XX, Liang X, Li SR, Guo KJ, Li DF, Li TF. Bone Marrow Mesenchymal Stem Cells Overexpressing HIF-1α Prevented the Progression of Glucocorticoid-Induced Avascular Osteonecrosis of Femoral Heads in Mice. Cell Transplant 2022;31:9636897221082687. [PMID: 35287482 DOI: 10.1177/09636897221082687] [Reference Citation Analysis]
8 Alkan U, Bachar G, Nachalon Y, Zlotogorsky A, Gal Levin E, Kaplan I. Proliferative verrucous leukoplakia: a clinicopathological comparative study. International Journal of Oral and Maxillofacial Surgery 2022. [DOI: 10.1016/j.ijom.2022.01.002] [Reference Citation Analysis]
9 He L, Chang H, Qi Y, Zhang B, Shao Q. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer. Technol Cancer Res Treat 2021;20:15330338211062313. [PMID: 34908512 DOI: 10.1177/15330338211062313] [Reference Citation Analysis]
10 Shaji S, Smith C, Forget P. Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis. Curr Oncol Rep 2021;23:146. [PMID: 34748112 DOI: 10.1007/s11912-021-01133-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Liu Y, Pang Z, Zhao X, Zeng Y, Shen H, Du J. Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma. PeerJ 2021;9:e12275. [PMID: 34707942 DOI: 10.7717/peerj.12275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Selvaraj J, Vishnupriya V, Sardar H, Balakrishna JP, Rex J, Mohan SK, Vijayalakshmi P, Ponnulakshmi R. Molecular docking analysis of COX-2 for potential inhibitors. Bioinformation 2020;16:753-8. [PMID: 34675461 DOI: 10.6026/97320630016753] [Reference Citation Analysis]
13 Wang D, Cabalag CS, Clemons NJ, DuBois RN. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. Gastroenterology 2021;161:1813-29. [PMID: 34606846 DOI: 10.1053/j.gastro.2021.09.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Korbecki J, Simińska D, Gąssowska-Dobrowolska M, Listos J, Gutowska I, Chlubek D, Baranowska-Bosiacka I. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms. Int J Mol Sci 2021;22:10701. [PMID: 34639040 DOI: 10.3390/ijms221910701] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
15 Yaqub S, Bjørnbeth BA, Angelsen JH, Fristrup CW, Grønbech JE, Hemmingsson O, Isaksson B, Juel IS, Larsen PN, Lindell G, Mortensen FV, Mortensen KE, Rizell M, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Taskén K; ASAC study group. Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial. Trials 2021;22:642. [PMID: 34544470 DOI: 10.1186/s13063-021-05587-w] [Reference Citation Analysis]
16 Tudor DV, Bâldea I, Lupu M, Kacso T, Kutasi E, Hopârtean A, Stretea R, Gabriela Filip A. COX-2 as a potential biomarker and therapeutic target in melanoma. Cancer Biol Med 2020;17:20-31. [PMID: 32296574 DOI: 10.20892/j.issn.2095-3941.2019.0339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cuesta C, Arévalo-Alameda C, Castellano E. The Importance of Being PI3K in the RAS Signaling Network. Genes (Basel) 2021;12:1094. [PMID: 34356110 DOI: 10.3390/genes12071094] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Deng H, Kan A, Lyu N, He M, Huang X, Qiao S, Li S, Lu W, Xie Q, Chen H, Lai J, Chen Q, Jiang X, Liu S, Zhang Z, Zhao M. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. J Immunother Cancer 2021;9:e002305. [PMID: 34168004 DOI: 10.1136/jitc-2020-002305] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
19 Cao W, Ma X, Fischer JV, Sun C, Kong B, Zhang Q. Immunotherapy in endometrial cancer: rationale, practice and perspectives. Biomark Res 2021;9:49. [PMID: 34134781 DOI: 10.1186/s40364-021-00301-z] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
20 de la Cruz-Ojeda P, Flores-Campos R, Dios-Barbeito S, Navarro-Villarán E, Muntané J. Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAs. Int J Mol Sci 2021;22:6264. [PMID: 34200849 DOI: 10.3390/ijms22126264] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 Morin C, Patel Y, Javid M, Tevis SE, Fortes T, Flom P, Andaz C, Manasseh DM, Borgen P, Rojas KE. Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control. Ann Surg Oncol 2021. [PMID: 34076809 DOI: 10.1245/s10434-021-09963-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Moussa N, Hassan A, Gharaghani S. Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors. Heliyon 2021;7:e06605. [PMID: 33889764 DOI: 10.1016/j.heliyon.2021.e06605] [Reference Citation Analysis]
23 Seeger DR, Golovko SA, Grove BD, Golovko MY. Cyclooxygenase inhibition attenuates brain angiogenesis and independently decreases mouse survival under hypoxia. J Neurochem 2021;158:246-61. [PMID: 33389746 DOI: 10.1111/jnc.15291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Liang S, Yu H. Revealing new therapeutic opportunities through drug target prediction: a class imbalance-tolerant machine learning approach. Bioinformatics 2020;36:4490-7. [PMID: 32399556 DOI: 10.1093/bioinformatics/btaa495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tubin S, Khan MK, Gupta S, Jeremic B. Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment. Cancers (Basel) 2021;13:775. [PMID: 33673332 DOI: 10.3390/cancers13040775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Yang SJ, An JH, Park SM, Lee JH, Chae HK, Lee KM, Song WJ, Youn HY. Enhanced expression of cyclooxygenase-2 related multi-drug resistance gene in melanoma and osteosarcoma cell lines by TSG-6 secreted from canine adipose-derived mesenchymal stem/stromal cells. Vet Med Sci 2021;7:968-78. [PMID: 33570264 DOI: 10.1002/vms3.442] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Olivier C, Oliver L, Lalier L, Vallette FM. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Front Mol Biosci 2020;7:620677. [PMID: 33585565 DOI: 10.3389/fmolb.2020.620677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
28 Sougiannis AT, VanderVeen BN, Davis JM, Fan D, Murphy EA. Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. Am J Physiol Gastrointest Liver Physiol 2021;320:G712-9. [PMID: 33471628 DOI: 10.1152/ajpgi.00380.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
29 Chadha P, Ranjan R, Kumar N, Vardhan R, Sengupta P, Negi R. Immunohistochemical analysis and correlation of cyclooxygenase-2 expression status with clinicopathological parameters in head and neck squamous cell carcinomas: An Indian perspective. J Oral Maxillofac Pathol 2020;24:583. [PMID: 33967512 DOI: 10.4103/jomfp.JOMFP_128_20] [Reference Citation Analysis]
30 Perisetti A, Goyal H, Tharian B, Inamdar S, Mehta JL. Aspirin for prevention of colorectal cancer in the elderly: friend or foe? Ann Gastroenterol 2021;34:1-11. [PMID: 33414615 DOI: 10.20524/aog.2020.0556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Klochkov SG, Neganova ME, Aleksandrova YR. Promising Molecular Targets for Design of Antitumor Drugs Based on Ras Protein Signaling Cascades. Russ J Bioorg Chem 2020;46:891-902. [DOI: 10.1134/s1068162020050118] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Medina MV, D Agostino A, Ma Q, Eroles P, Cavallin L, Chiozzini C, Sapochnik D, Cymeryng C, Hyjek E, Cesarman E, Naipauer J, Mesri EA, Coso OA. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. PLoS Pathog 2020;16:e1009006. [PMID: 33057440 DOI: 10.1371/journal.ppat.1009006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Picado C, Roca-Ferrer J. Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer. J Clin Med 2020;9:E3237. [PMID: 33050416 DOI: 10.3390/jcm9103237] [Reference Citation Analysis]
34 Bhaskaran M, Devegowda VG, Gupta VK, Shivachar A, Bhosale RR, Arunachalam M, Vaishnavi T. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme. ACS Chem Neurosci 2020;11:2962-77. [PMID: 32945654 DOI: 10.1021/acschemneuro.0c00555] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
35 Cekanova M, Pandey S, Olin S, Ryan P, Stokes JE, Hecht S, Martin-Jimenez T, Uddin MJ, Marnett LJ. Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer. J Biomed Opt 2020;25. [PMID: 32860356 DOI: 10.1117/1.JBO.25.8.086005] [Reference Citation Analysis]
36 Neitzel C, Demuth P, Wittmann S, Fahrer J. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities. Cancers (Basel) 2020;12:E1731. [PMID: 32610612 DOI: 10.3390/cancers12071731] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
37 Piotrowski I, Kulcenty K, Suchorska W. Interplay between inflammation and cancer. Rep Pract Oncol Radiother 2020;25:422-7. [PMID: 32372882 DOI: 10.1016/j.rpor.2020.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
38 Venkatachalam K, Vinayagam R, Arokia Vijaya Anand M, Isa NM, Ponnaiyan R. Biochemical and molecular aspects of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis: a review. Toxicol Res (Camb) 2020;9:2-18. [PMID: 32440334 DOI: 10.1093/toxres/tfaa004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
39 Sart S, Tomasi RF, Barizien A, Amselem G, Cumano A, Baroud CN. Mapping the structure and biological functions within mesenchymal bodies using microfluidics. Sci Adv 2020;6:eaaw7853. [PMID: 32181333 DOI: 10.1126/sciadv.aaw7853] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
40 Bergès R, Tchoghandjian A, Sergé A, Honoré S, Figarella-Branger D, Bachmann F, Lane HA, Braguer D. EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis. Oncotarget 2020;11:759-74. [PMID: 32165998 DOI: 10.18632/oncotarget.27374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Huang J, Diao G, Zhang Q, Chen Y, Han J, Guo J. E6‑regulated overproduction of prostaglandin E2 may inhibit migration of dendritic cells in human papillomavirus 16‑positive cervical lesions. Int J Oncol 2020;56:921-31. [PMID: 32319556 DOI: 10.3892/ijo.2020.4983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
42 Guo SW. The Pathogenesis of Adenomyosis vis-à-vis Endometriosis. J Clin Med 2020;9:E485. [PMID: 32050720 DOI: 10.3390/jcm9020485] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
43 Qi Q, Liu X, Zhang Q, Guo SW. Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells. Sci Rep 2020;10:1281. [PMID: 31992765 DOI: 10.1038/s41598-020-57997-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
44 Oh JM, Venters CC, Di C, Pinto AM, Wan L, Younis I, Cai Z, Arai C, So BR, Duan J, Dreyfuss G. U1 snRNP regulates cancer cell migration and invasion in vitro. Nat Commun 2020;11:1. [PMID: 31911652 DOI: 10.1038/s41467-019-13993-7] [Cited by in Crossref: 459] [Cited by in F6Publishing: 1303] [Article Influence: 229.5] [Reference Citation Analysis]
45 Zhu H, Han W, Gan Y, Li Q, Li X, Shao L, Zhu D, Guo H. Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma. Pharmaceutics 2019;11:E683. [PMID: 31847496 DOI: 10.3390/pharmaceutics11120683] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
46 Patan-Zugaj B, Egerbacher M, Licka TF. Endotoxin-induced changes in expression of cyclooxygenase isoforms in the lamellar tissue of extracorporeally haemoperfused equine limbs. Anat Histol Embryol 2020;49:597-605. [PMID: 31774594 DOI: 10.1111/ahe.12520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Tago K, Funakoshi-Tago M, Ohta S, Kawata H, Saitoh H, Horie H, Aoki-Ohmura C, Yamauchi J, Tanaka A, Matsugi J, Yanagisawa K. Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation. Mol Oncol 2019;13:2493-510. [PMID: 31580526 DOI: 10.1002/1878-0261.12580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
48 Lim HJ, Park J, Um JY, Lee SS, Kwak HJ. Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation. Cells 2019;8:E1182. [PMID: 31575085 DOI: 10.3390/cells8101182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Zhang X, Qu P, Zhao H, Zhao T, Cao N. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling. Mol Med Rep 2019;20:3811-9. [PMID: 31485669 DOI: 10.3892/mmr.2019.10598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lin CK, Lin YH, Huang TC, Shi CS, Yang CT, Yang YL. VEGF mediates fat embolism-induced acute lung injury via VEGF receptor 2 and the MAPK cascade. Sci Rep 2019;9:11713. [PMID: 31406128 DOI: 10.1038/s41598-019-47276-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
51 Korga A, Ostrowska M, Iwan M, Skierucha M, Józefczyk A, Pawłowski P, Dudka J, Maciejewski R, Sitarz R. Ethanol extracts of Allium sp. regulate cyclooxygenase-2 and E-cadherin expression in gastric cancer MKN74 cell line and enhance doxorubicin toxicity. Food Nutr Res 2019;63. [PMID: 31297043 DOI: 10.29219/fnr.v63.3449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
52 Negi RR, Rana SV, Gupta V, Gupta R, Chadha VD, Prasad KK, Dhawan DK. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients. Asian Pac J Cancer Prev 2019;20:1675-81. [PMID: 31244287 DOI: 10.31557/APJCP.2019.20.6.1675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
53 Magee DJ, Jhanji S, Poulogiannis G, Farquhar-Smith P, Brown MRD. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. Br J Anaesth 2019;123:e412-23. [PMID: 31122736 DOI: 10.1016/j.bja.2019.02.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
54 Zhang X, Feng Y, Liu X, Ma J, Li Y, Wang T, Li X. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer. J Cancer Res Clin Oncol 2019;145:1387-403. [PMID: 31037399 DOI: 10.1007/s00432-019-02902-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
55 Al-Maghrabi B, Gomaa W, Abdelwahed M, Al-Maghrabi J. Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis. Anal Cell Pathol (Amst) 2019;2019:5026939. [PMID: 31179232 DOI: 10.1155/2019/5026939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Horikirizono H, Ishigaki K, Amaha T, Iizuka K, Nagumo T, Tamura K, Seki M, Edamura K, Asano K. Inhibition of growth of canine-derived vascular endothelial cells by non-steroidal anti-inflammatory drugs and atrial natriuretic peptide. J Vet Med Sci 2019;81:776-9. [PMID: 30930345 DOI: 10.1292/jvms.18-0575] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Liu J, Curtin J, You D, Hillerman S, Li-Wang B, Eraslan R, Xie J, Swanson J, Ho CP, Oppenheimer S, Warrack BM, McNaney CA, Nelson DM, Blum J, Kim T, Fereshteh M, Reily M, Shipkova P, Murtaza A, Sanjuan M, Hunt JT, Salter-Cid L. Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance. PLoS One 2019;14:e0212670. [PMID: 30913212 DOI: 10.1371/journal.pone.0212670] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
58 Schmidt A, von Woedtke T, Vollmar B, Hasse S, Bekeschus S. Nrf2 signaling and inflammation are key events in physical plasma-spurred wound healing. Theranostics 2019;9:1066-84. [PMID: 30867816 DOI: 10.7150/thno.29754] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 17.3] [Reference Citation Analysis]
59 Wang S, Gao H, Zuo J, Gao Z. Cyclooxygenase-2 expression correlates with development, progression, metastasis, and prognosis of osteosarcoma: a meta-analysis and trial sequential analysis. FEBS Open Bio 2019;9:226-40. [PMID: 30761249 DOI: 10.1002/2211-5463.12560] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
60 Budi EH, Mamai O, Hoffman S, Akhurst RJ, Derynck R. Enhanced TGF-β Signaling Contributes to the Insulin-Induced Angiogenic Responses of Endothelial Cells. iScience 2019;11:474-91. [PMID: 30684493 DOI: 10.1016/j.isci.2018.12.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
61 Jiang W, Wang L, Zhang J, Shen H, Dong W, Zhang T, Li X, Wang K, Du J. Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer. Medicine (Baltimore) 2018;97:e12442. [PMID: 30278522 DOI: 10.1097/MD.0000000000012442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
62 Punganuru SR, Madala HR, Mikelis CM, Dixit A, Arutla V, Srivenugopal KS. Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models. Oncotarget 2018;9:26109-29. [PMID: 29899846 DOI: 10.18632/oncotarget.25450] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
63 Xie C, Xu X, Wang X, Wei S, Shao L, Chen J, Cai J, Jia L. Cyclooxygenase-2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E2. Oncol Lett. 2018;16:940-948. [PMID: 29963167 DOI: 10.3892/ol.2018.8786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
64 Castro-López J, Ramis A, Planellas M, Teles M, Pastor J. Cyclooxygenase-2 immunoexpression in intestinal epithelium and lamina propria of cats with inflammatory bowel disease and low grade alimentary lymphoma. BMC Vet Res 2018;14:158. [PMID: 29764431 DOI: 10.1186/s12917-018-1486-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
65 Jalota A, Kumar M, Das BC, Yadav AK, Chosdol K, Sinha S. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells. Oncotarget 2018;9:18351-66. [PMID: 29719610 DOI: 10.18632/oncotarget.24839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
66 Du P, Xu B, Zhang D, Shao Y, Zheng X, Li X, Xiong Y, Wu C, Jiang J. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma. Oncotarget 2017;8:954-66. [PMID: 27888614 DOI: 10.18632/oncotarget.13512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
67 Okada CTC, Segabinazzi LG, Crespilho AM, Dell'aqua JA, Alvarenga MA. Effect of the Flunixin Meglumine on Pregnancy Rates in an Equine Embryo Transfer Program. Journal of Equine Veterinary Science 2018;62:40-3. [DOI: 10.1016/j.jevs.2017.10.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
68 Aravindan S, Ramraj S, Kandasamy K, Thirugnanasambandan SS, Somasundaram DB, Herman TS, Aravindan N. Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells. Oncotarget 2017;8:5717-34. [PMID: 27974694 DOI: 10.18632/oncotarget.13900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
69 Grabosch SM, Shariff OM, Helm CW. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2018;2:CD004121. [PMID: 29431861 DOI: 10.1002/14651858.CD004121.pub4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
70 Angelucci A, Delle Monache S, Cortellini A, Di Padova M, Ficorella C. "Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer. Int J Mol Sci 2018;19:E299. [PMID: 29351242 DOI: 10.3390/ijms19010299] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
71 Huang CY, Lee CH, Tu CC, Wu CH, Huang MT, Wei PL, Chang YJ. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis. Oncotarget 2018;9:9425-41. [PMID: 29507700 DOI: 10.18632/oncotarget.24114] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
72 Jiang Q. Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy. Adv Nutr 2017;8:850-67. [PMID: 29141970 DOI: 10.3945/an.117.016329] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
73 Cui Y, Chen LG, Yao HB, Zhang J, Ding KF. Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells. Oncol Lett 2018;15:1184-90. [PMID: 29399173 DOI: 10.3892/ol.2017.7409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
74 Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol 2018;148:222-32. [PMID: 29132875 DOI: 10.1016/j.ygyno.2017.10.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
75 Liu D, Peng C, Jiang Z, Tao L. Relationship between expression of cyclooxygenase 2 and neovascularization in human pterygia. Oncotarget 2017;8:105630-6. [PMID: 29285278 DOI: 10.18632/oncotarget.22351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
76 Zhang Z, Zheng F, Yu Z, Hao J, Chen M, Yu W, Guo W, Chen Y, Huang W, Duan Z, Deng W. XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers. PLoS One 2017;12:e0186900. [PMID: 29049411 DOI: 10.1371/journal.pone.0186900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
77 Jeong H, Baek SY, Kim SW, Eun YH, Kim IY, Lee J, Jeon CH, Koh EM, Cha HS. Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). PLoS One 2017;12:e0186141. [PMID: 29045425 DOI: 10.1371/journal.pone.0186141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
78 Sun H, Zhang X, Sun D, Jia X, Xu L, Qiao Y, Jin Y. COX-2 expression in ovarian cancer: an updated meta-analysis. Oncotarget 2017;8:88152-62. [PMID: 29152148 DOI: 10.18632/oncotarget.21538] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
79 Sato-Dahlman M, Miura Y, Huang JL, Hajeri P, Jacobsen K, Davydova J, Yamamoto M. CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer. Oncotarget 2017;8:76044-56. [PMID: 29100290 DOI: 10.18632/oncotarget.18340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Ho Y, Lin YS, Liu HL, Shih YJ, Lin SY, Shih A, Chin YT, Chen YR, Lin HY, Davis PJ. Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized. Nutrients 2017;9:E1046. [PMID: 28934112 DOI: 10.3390/nu9101046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
81 Cho IS, Chae YR, Kim JH, Yoo HR, Jang SY, Kim GR, Nam CM. Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study. BMC Med Res Methodol 2017;17:126. [PMID: 28830373 DOI: 10.1186/s12874-017-0405-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
82 Kong LL, Yang NZ, Shi LH, Zhao GH, Zhou W, Ding Q, Wang MH, Zhang YS. The optimum marker for the detection of lymphatic vessels. Mol Clin Oncol 2017;7:515-20. [PMID: 28855985 DOI: 10.3892/mco.2017.1356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
83 Garrido P, Shalaby A, Walsh EM, Keane N, Webber M, Keane MM, Sullivan FJ, Kerin MJ, Callagy G, Ryan AE, Glynn SA. Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways. Oncotarget 2017;8:80568-88. [PMID: 29113326 DOI: 10.18632/oncotarget.19631] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
84 Tak KH, Ahn E, Kim E. Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis. Nutr Res Pract 2017;11:281-9. [PMID: 28765774 DOI: 10.4162/nrp.2017.11.4.281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
85 Wu M, Guan J, Li C, Gunter S, Nusrat L, Ng S, Dhand K, Morshead C, Kim A, Das S. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma. Oncotarget 2017;8:82217-30. [PMID: 29137258 DOI: 10.18632/oncotarget.19283] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
86 Sato-Dahlman M, Miura Y, Huang JL, Hajeri P, Jacobsen K, Davydova J, Yamamoto M. CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer. Oncotarget 2017;8:76044-56. [PMID: 29100290 DOI: 10.18632/oncotarget.18340] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
87 Olson J, Amolins M, Vitiello P. Creating a Reliable, Cost-Effective ELISA Simulation. Am Biol Teach 2017;79:301-4. [PMID: 29033458 DOI: 10.1525/abt.2017.79.4.301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
88 Gandhi J, Khera L, Gaur N, Paul C, Kaul R. Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis. Front Microbiol 2017;8:538. [PMID: 28400769 DOI: 10.3389/fmicb.2017.00538] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
89 Mostofa AG, Punganuru SR, Madala HR, Al-Obaide M, Srivenugopal KS. The Process and Regulatory Components of Inflammation in Brain Oncogenesis. Biomolecules 2017;7:E34. [PMID: 28346397 DOI: 10.3390/biom7020034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
90 Li Z, Chang CM, Wang L, Zhang P, Shu HG. Cyclooxygenase-2 Induction by Amino Acid Deprivation Requires p38 Mitogen-Activated Protein Kinase in Human Glioma Cells. Cancer Invest 2017;35:237-47. [PMID: 28333553 DOI: 10.1080/07357907.2017.1292517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
91 Wang J, Yao X, Huang J. New tricks for human farnesyltransferase inhibitor: cancer and beyond. Medchemcomm 2017;8:841-54. [PMID: 30108801 DOI: 10.1039/c7md00030h] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
92 Zumwalt TJ, Wodarz D, Komarova NL, Toden S, Turner J, Cardenas J, Burn J, Chan AT, Boland CR, Goel A. Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells. Cancer Prev Res (Phila) 2017;10:208-18. [PMID: 28154202 DOI: 10.1158/1940-6207.CAPR-16-0175] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
93 Liu B, Yan S, Qu L, Zhu J. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell Int 2017;17:1. [PMID: 28053596 DOI: 10.1186/s12935-016-0378-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
94 Egginton S, Hussain A, Hall-Jones J, Chaudhry B, Syeda F, Glen KE. Shear stress-induced angiogenesis in mouse muscle is independent of the vasodilator mechanism and quickly reversible. Acta Physiol (Oxf) 2016;218:153-66. [PMID: 27261201 DOI: 10.1111/apha.12728] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
95 Thoompumkal IJ, Rehna K, Anbarasu K, Mahalingam S. Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation. Cell Cycle 2016;15:3251-67. [PMID: 27764577 DOI: 10.1080/15384101.2016.1242534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
96 Saloustros E, Liu S, Mertz EL, Bhattacharyya N, Starost MF, Salpea P, Nesterova M, Collins M, Leikin S, Stratakis CA. Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects. Mol Cell Endocrinol 2017;439:165-74. [PMID: 27498419 DOI: 10.1016/j.mce.2016.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
97 Adefuye AO, Adeola HA, Sales KJ, Katz AA. Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract. J Immunol Res 2016;2016:9707252. [PMID: 27446968 DOI: 10.1155/2016/9707252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
98 Wehbi VL, Taskén K. Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units. Front Immunol 2016;7:222. [PMID: 27375620 DOI: 10.3389/fimmu.2016.00222] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 13.7] [Reference Citation Analysis]
99 Liu Q, Huang Y, Zhang R, Cai T, Cai Y. Medical Application of Spirulina platensis Derived C-Phycocyanin. Evid Based Complement Alternat Med 2016;2016:7803846. [PMID: 27293463 DOI: 10.1155/2016/7803846] [Cited by in Crossref: 31] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
100 Ravula P, Vamaraju HB, Paturi M, Chandra Jn NS, Kolli S. Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents. EXCLI J 2016;15:187-202. [PMID: 27103897 DOI: 10.17179/excli2016-103] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
101 Madonna R, Giovannelli G, Confalone P, Renna FV, Geng YJ, De Caterina R. High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy. Cardiovasc Diabetol 2016;15:18. [PMID: 26822858 DOI: 10.1186/s12933-016-0342-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
102 Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 2016;5:e189. [PMID: 26807644 DOI: 10.1038/oncsis.2015.49] [Cited by in Crossref: 617] [Cited by in F6Publishing: 665] [Article Influence: 102.8] [Reference Citation Analysis]
103 Márquez J, Mena J, Hernandez-Unzueta I, Benedicto A, Sanz E, Arteta B, Olaso E. Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice. Oncol Rep 2016;35:1265-72. [PMID: 26676882 DOI: 10.3892/or.2015.4486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
104 Tuncer S, Banerjee S. Eicosanoid pathway in colorectal cancer: Recent updates. World J Gastroenterol 2015; 21(41): 11748-11766 [PMID: 26557000 DOI: 10.3748/wjg.v21.i41.11748] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
105 Liu B, Qu L, Yan S. Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int. 2015;15:106. [PMID: 26549987 DOI: 10.1186/s12935-015-0260-7] [Cited by in Crossref: 140] [Cited by in F6Publishing: 190] [Article Influence: 20.0] [Reference Citation Analysis]
106 Zhang N, Subbaramaiah K, Yantiss RK, Zhou XK, Chin Y, Scherl EJ, Bosworth BP, Benezra R, Dannenberg AJ. Id1 expression in endothelial cells of the colon is required for normal response to injury. Am J Pathol 2015;185:2983-93. [PMID: 26348574 DOI: 10.1016/j.ajpath.2015.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
107 Li H, Guo Q, Zhou B, He S. Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: A population-based study. Oncol Lett 2015;10:1863-9. [PMID: 26622766 DOI: 10.3892/ol.2015.3477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
108 Qu L, Liu B. Cyclooxygeanse-2 promotes metastasis in osteosarcoma. Cancer Cell Int 2015;15:69. [PMID: 26180515 DOI: 10.1186/s12935-015-0220-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
109 Liu J, You P, Chen G, Fu X, Zeng X, Wang C, Huang Y, An L, Wan X, Navone N, Wu CL, McKeehan WL, Zhang Z, Zhong W, Wang F. Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients. Oncogene 2016;35:1750-9. [PMID: 26096936 DOI: 10.1038/onc.2015.239] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
110 Byatnal AA, Byatnal A, Sen S, Guddattu V, Solomon MC. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study. Pathol Oncol Res 2015;21:1123-31. [PMID: 25962348 DOI: 10.1007/s12253-015-9940-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
111 French CL, Ye F, Revetta F, Zhang B, Coffey RJ, Washington MK, Deane NG, Beauchamp RD, Weaver AM. Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. F1000Res 2015;4:99. [PMID: 26097693 DOI: 10.12688/f1000research.6388.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
112 Alexanian A, Miller B, Chesnik M, Mirza S, Sorokin A. Post-translational regulation of COX2 activity by FYN in prostate cancer cells. Oncotarget 2014;5:4232-43. [PMID: 24970799 DOI: 10.18632/oncotarget.1983] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
113 Harizi H. Epigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequences. Mediators Inflamm 2015;2015:841097. [PMID: 25944989 DOI: 10.1155/2015/841097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
114 Yuan G, Yan S, Xue H, Zhang P, Sun J, Li G. JSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitro. PLoS One 2015;10:e0118894. [PMID: 25789853 DOI: 10.1371/journal.pone.0118894] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
115 Qi G, Tang BO, Zhou L, Jikihara H, Kiwata A, Sakamoto Y, Tang F, Xiao S, Wang Z, Wu Q, Lu H, Wu Z, Zeng S, Shimamoto F. Effects of high-fat diet on 1,2-dimethylhydrazine-induced aberrant crypt foci and colorectal tumours in rats. Biomed Rep 2015;3:289-94. [PMID: 26137224 DOI: 10.3892/br.2015.433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
116 Banno K, Iida M, Yanokura M, Irie H, Masuda K, Kobayashi Y, Tominaga E, Aoki D. Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer. ScientificWorldJournal 2015;2015:341362. [PMID: 25734181 DOI: 10.1155/2015/341362] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
117 Lall RK, Syed DN, Adhami VM, Khan MI, Mukhtar H. Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci 2015;16:3350-76. [PMID: 25654230 DOI: 10.3390/ijms16023350] [Cited by in Crossref: 112] [Cited by in F6Publishing: 110] [Article Influence: 16.0] [Reference Citation Analysis]
118 Xu K, Wang L, Shu HK. COX-2 overexpression increases malignant potential of human glioma cells through Id1. Oncotarget 2014;5:1241-52. [PMID: 24659686 DOI: 10.18632/oncotarget.1370] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
119 Kumagai T, Usami H, Matsukawa N, Nakashima F, Chikazawa M, Shibata T, Noguchi N, Uchida K. Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile. Redox Biol 2015;4:74-86. [PMID: 25506925 DOI: 10.1016/j.redox.2014.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
120 Lee MH, Kachroo P, Pagano PC, Yanagawa J, Wang G, Walser TC, Krysan K, Sharma S, John MS, Dubinett SM, Lee JM. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. J Cancer Sci Ther 2014;6:468-77. [PMID: 26523208 DOI: 10.4172/1948-5956.1000310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
121 Hiľovská L, Jendželovský R, Fedoročko P. Potency of non-steroidal anti-inflammatory drugs in chemotherapy. Mol Clin Oncol 2015;3:3-12. [PMID: 25469262 DOI: 10.3892/mco.2014.446] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
122 Aihara H, Kumar N, Thompson CC. Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update. Eur J Gastroenterol Hepatol 2014;26:255-62. [PMID: 24161962 DOI: 10.1097/MEG.0000000000000010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
123 Pang LY, Argyle SA, Kamida A, Morrison KO, Argyle DJ. The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Vet Res 2014;10:184. [PMID: 25190452 DOI: 10.1186/s12917-014-0184-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
124 Lee H, Park W, Ryu H, Jeon NL. A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation. Biomicrofluidics 2014;8:054102. [PMID: 25332739 DOI: 10.1063/1.4894595] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 9.5] [Reference Citation Analysis]
125 Nguyen T, Tang Z, Younes M, Alsarraj A, Ramsey D, Fitzgerald S, Kramer JR, El-Serag HB. Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci 2015;60:65-73. [PMID: 25185658 DOI: 10.1007/s10620-014-3333-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
126 Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang L, Wang X, Wang C, Huo X, Yu W, Yi C, Xiao Y, Yang W, Qin Y, Yuan Y, Meng S, Liu Q, Deng W. Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer 2014;13:203. [PMID: 25175164 DOI: 10.1186/1476-4598-13-203] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
127 Bhat IA, Rasool R, Qasim I, Masoodi KZ, Paul SA, Bhat BA, Ganaie FA, Aziz SA, Shah ZA. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer. Tumour Biol 2014;35:11209-18. [PMID: 25113252 DOI: 10.1007/s13277-014-2420-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
128 Barone M, Pannuzzo G, Santagati A, Catalfo A, De Guidi G, Cardile V. Molecular docking and fluorescence characterization of benzothieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives, a novel class of selective cyclooxygenase-2 inhibitors. Molecules 2014;19:6106-22. [PMID: 24830713 DOI: 10.3390/molecules19056106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
129 Fujii R, Imanishi Y, Shibata K, Sakai N, Sakamoto K, Shigetomi S, Habu N, Otsuka K, Sato Y, Watanabe Y, Ozawa H, Tomita T, Kameyama K, Fujii M, Ogawa K. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. J Exp Clin Cancer Res 2014;33:40. [PMID: 24887090 DOI: 10.1186/1756-9966-33-40] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
130 Grabosch SM, Shariff OM, Wulff JL, Helm CW. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2014;:CD004121. [PMID: 24715225 DOI: 10.1002/14651858.CD004121.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
131 Yang JE, Park E, Lee HJ, Kang HJ, Kim KM, Yu E, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS. Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma. Clin Mol Hepatol 2014;20:28-37. [PMID: 24757656 DOI: 10.3350/cmh.2014.20.1.28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
132 Hong JM, Park CS, Nam-Goong IS, Kim YS, Lee JC, Han MW, Choi JI, Kim YI, Kim ES. Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells. Endocrinol Metab (Seoul) 2014;29:54-61. [PMID: 24741455 DOI: 10.3803/EnM.2014.29.1.54] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
133 Wu KK, Cheng HH, Chang TC. 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis. J Biomed Sci 2014;21:17. [PMID: 24589238 DOI: 10.1186/1423-0127-21-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
134 Jana D, Sarkar DK, Ganguly S, Saha S, Sa G, Manna AK, Banerjee A, Mandal S. Role of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer. Indian J Surg Oncol 2014;5:59-65. [PMID: 24669166 DOI: 10.1007/s13193-014-0290-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
135 Faloppa CC, Baiocchi G, Cunha IW, Fregnani JH, Osorio CA, Fukazawa EM, Kumagai LY, Badiglian-Filho L, Pinto GL, Soares FA. NF-κB and COX-2 expression in nonmalignant endometrial lesions and cancer. Am J Clin Pathol 2014;141:196-203. [PMID: 24436266 DOI: 10.1309/AJCPV7U7PGHOWEQG] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
136 Haas DA, Bala K, Büsche G, Weidner-Glunde M, Santag S, Kati S, Gramolelli S, Damas M, Dittrich-Breiholz O, Kracht M, Rückert J, Varga Z, Keri G, Schulz TF. The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells. PLoS Pathog 2013;9:e1003737. [PMID: 24244164 DOI: 10.1371/journal.ppat.1003737] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
137 Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK. Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches. Best Pract Res Clin Anaesthesiol 2013;27:409-25. [PMID: 24267548 DOI: 10.1016/j.bpa.2013.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
138 Leal AD, Thompson CA, Wang AH, Vierkant RA, Habermann TM, Ross JA, Mesa RA, Virnig BA, Cerhan JR. Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort. Int J Cancer 2014;134:1741-50. [PMID: 24114627 DOI: 10.1002/ijc.28492] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
139 Takai E, Tsukimoto M, Kojima S. TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1. PLoS One 2013;8:e76346. [PMID: 24098479 DOI: 10.1371/journal.pone.0076346] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
140 Symeonidis N, Papakonstantinou E, Psarras K, Ballas K, Pavlidis T, Karakiulakis G, Sakantamis A. The effect of celecoxib administration on the healing and neovascularization of colonic anastomosis in rats. J Invest Surg 2014;27:139-46. [PMID: 24087846 DOI: 10.3109/08941939.2013.842268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
141 Uddin S, Hussain AR, Khan OS, Al-Kuraya KS. Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis. Tumour Biol. 2014;35:871-879. [PMID: 24014051 DOI: 10.1007/s13277-013-1166-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
142 Wang XF, Huang MZ, Zhang XW, Hua RX, Guo WJ. COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis. PLoS One 2013;8:e73213. [PMID: 24023834 DOI: 10.1371/journal.pone.0073213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
143 Li J, Mansmann UR. Modeling of non-steroidal anti-inflammatory drug effect within signaling pathways and miRNA-regulation pathways. PLoS One 2013;8:e72477. [PMID: 23967306 DOI: 10.1371/journal.pone.0072477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
144 Jasiński M, Jasińska L, Ogrodowczyk M. Resveratrol in prostate diseases - a short review. Cent European J Urol 2013;66:144-9. [PMID: 24579014 DOI: 10.5173/ceju.2013.02.art8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
145 Fang H, Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013;73:4965-4977. [PMID: 23913938 DOI: 10.1158/0008-5472.can-13-0661] [Cited by in Crossref: 164] [Cited by in F6Publishing: 174] [Article Influence: 18.2] [Reference Citation Analysis]
146 Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. PLoS One 2013;8:e69660. [PMID: 23922772 DOI: 10.1371/journal.pone.0069660] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
147 Zhang MM, Peng T, Zhao K. Effect of endogenous and exogenous gastrin on PGE2 and EGF expression in dimethylhydrazine-induced colorectal cancer in rats. Shijie Huaren Xiaohua Zazhi 2013; 21(20): 1914-1924 [DOI: 10.11569/wcjd.v21.i20.1914] [Reference Citation Analysis]
148 Jiao G, Ren T, Lu Q, Sun Y, Lou Z, Peng X, Liang W, Guo W. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis. Tumour Biol 2013;34:2489-95. [PMID: 23857285 DOI: 10.1007/s13277-013-0998-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
149 Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014;33:2949-2955. [PMID: 23792451 DOI: 10.1038/onc.2013.244] [Cited by in Crossref: 83] [Cited by in F6Publishing: 94] [Article Influence: 9.2] [Reference Citation Analysis]
150 Zhou LH, Hu Q, Sui H, Ci SJ, Wang Y, Liu X, Liu NN, Yin PH, Qin JM, Li Q. Tanshinone II--a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Asian Pac J Cancer Prev 2012;13:4453-8. [PMID: 23167360 DOI: 10.7314/apjcp.2012.13.9.4453] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
151 Wang LJ, Bai L, Su D, Zhang T, Mao ZY. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Mol Cell Biochem 2013;381:173-81. [PMID: 23749165 DOI: 10.1007/s11010-013-1700-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
152 Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM. COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128. Int J Gynecol Cancer 2013;23:176-83. [PMID: 23221733 DOI: 10.1097/IGC.0b013e3182791efc] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
153 Sierra JC, Hobbs S, Chaturvedi R, Yan F, Wilson KT, Peek RM, Polk DB. Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;305:G196-G203. [PMID: 23681474 DOI: 10.1152/ajpgi.00495.2012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
154 Martin CK, Dirksen WP, Carlton MM, Lanigan LG, Pillai SP, Werbeck JL, Simmons JK, Hildreth BE 3rd, London CA, Toribio RE, Rosol TJ. Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma. Vet Comp Oncol 2015;13:203-17. [PMID: 23651067 DOI: 10.1111/vco.12037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
155 Na YR, Yoon YN, Son DI, Seok SH. Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One 2013;8:e63451. [PMID: 23667623 DOI: 10.1371/journal.pone.0063451] [Cited by in Crossref: 96] [Cited by in F6Publishing: 105] [Article Influence: 10.7] [Reference Citation Analysis]
156 Hernández-Pedro NY, Rangel-López E, Magaña-Maldonado R, de la Cruz VP, del Angel AS, Pineda B, Sotelo J. Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int 2013;2013:351031. [PMID: 23691498 DOI: 10.1155/2013/351031] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
157 Cekanova M, Uddin MJ, Legendre AM, Galyon G, Bartges JW, Callens A, Martin-Jimenez T, Marnett LJ. Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model. J Biomed Opt 2012;17:116002. [PMID: 23117797 DOI: 10.1117/1.JBO.17.11.116002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
158 Kera Y, Katoh Y, Ohta M, Matsumoto M, Takano-Yamamoto T, Igarashi K. Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus. J Biol Chem 2013;288:13592-601. [PMID: 23539621 DOI: 10.1074/jbc.M112.429738] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
159 Harizi H. Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cell Mol Immunol 2013;10:213-21. [PMID: 23524652 DOI: 10.1038/cmi.2013.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
160 Kaczanowska S, Joseph AM, Davila E. TLR agonists: our best frenemy in cancer immunotherapy. J Leukoc Biol. 2013;93:847-863. [PMID: 23475577 DOI: 10.1189/jlb.1012501] [Cited by in Crossref: 188] [Cited by in F6Publishing: 201] [Article Influence: 20.9] [Reference Citation Analysis]
161 Ryu YM, Myung SJ, Park YS, Yang DH, Song HJ, Jeong JY, Lee SM, Song M, Kim do H, Lee HJ. Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis. Cancer Prev Res (Phila). 2013;6:349-359. [PMID: 23430757 DOI: 10.1158/1940-6207.CAPR-12-0389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
162 Yang S, Jiang L, Zhang MZ. 11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal Tumorigenesis. J Oncobiomarkers 2013;1:002. [PMID: 23936870 DOI: 10.13188/2325-2340.1000002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
163 Friedrich S, Schwabe K, Grote M, Krauss JK, Nakamura M. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice. Acta Neurochir (Wien) 2013;155:173-82. [PMID: 23143216 DOI: 10.1007/s00701-012-1534-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
164 Srimuangwong K, Tocharus C, Tocharus J, Suksamrarn A, Yoysungnoen Chintana P. Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats. World J Gastroenterol 2012; 18(47): 6951-6959 [PMID: 23322993 DOI: 10.3748/wjg.v18.i47.6951] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
165 Dai ZJ, Ma XB, Kang HF, Gao J, Min WL, Guan HT, Diao Y, Lu WF, Wang XJ. Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo. Cancer Cell Int 2012;12:53. [PMID: 23249419 DOI: 10.1186/1475-2867-12-53] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
166 Chueca E, Lanas A, Piazuelo E. Role of gastrin-peptides in Barrett's and colorectal carcinogenesis. World J Gastroenterol 2012; 18(45): 6560-6570 [PMID: 23236230 DOI: 10.3748/wjg.v18.i45.6560] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
167 Garufi A, Pistritto G, Ceci C, Di Renzo L, Santarelli R, Faggioni A, Cirone M, D'Orazi G. Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation. PLoS One 2012;7:e48342. [PMID: 23144866 DOI: 10.1371/journal.pone.0048342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
168 Law PC, Auyeung KK, Chan LY, Ko JK. Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. BMC Complement Altern Med 2012;12:160. [PMID: 22992293 DOI: 10.1186/1472-6882-12-160] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
169 Yalniz M, Demirel U, Orhan C, Bahcecioglu IH, Ozercan IH, Aygun C, Tuzcu M, Sahin K. Nadroparin sodium activates Nrf2/HO-1 pathway in acetic acid-induced colitis in rats. Inflammation 2012;35:1213-21. [PMID: 22350949 DOI: 10.1007/s10753-012-9431-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
170 Park JI, Kwak JY. The role of peroxisome proliferator-activated receptors in colorectal cancer. PPAR Res 2012;2012:876418. [PMID: 23024650 DOI: 10.1155/2012/876418] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
171 Kim DH, Gutierrez-Aguilar R, Kim HJ, Woods SC, Seeley RJ. Increased adipose tissue hypoxia and capacity for angiogenesis and inflammation in young diet-sensitive C57 mice compared with diet-resistant FVB mice. Int J Obes (Lond) 2013;37:853-60. [PMID: 22964790 DOI: 10.1038/ijo.2012.141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
172 Muangnoi C, Chingsuwanrote P, Praengamthanachoti P, Svasti S, Tuntipopipat S. Moringa oleifera pod inhibits inflammatory mediator production by lipopolysaccharide-stimulated RAW 264.7 murine macrophage cell lines. Inflammation 2012;35:445-55. [PMID: 21537903 DOI: 10.1007/s10753-011-9334-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
173 Mohammad S, Ram H, Gupta PN, Husain N, Bhatt ML. Overexpression of COX-2 in oral squamous cell carcinoma patients undergoing chemoradiotherapy. Natl J Maxillofac Surg 2011;2:17-21. [PMID: 22442604 DOI: 10.4103/0975-5950.85848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
174 Karnezis T, Shayan R, Fox S, Achen MG, Stacker SA. The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway. Oncotarget 2012;3:893-906. [PMID: 23097685 DOI: 10.18632/oncotarget.593] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
175 Cheng HH, Kuo CC, Yan JL, Chen HL, Lin WC, Wang KH, Tsai KK, Guvén H, Flaberg E, Szekely L, Klein G, Wu KK. Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. Proc Natl Acad Sci U S A 2012;109:13231-6. [PMID: 22851770 DOI: 10.1073/pnas.1209919109] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
176 Pérez-Ruiz E, Cazorla O, Redondo M, Pérez L, Álvarez M, Gallego E, Trigo JM, Medina JA, Matilla A, Rueda A. Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation. Clin Transl Oncol 2012;14:682-8. [PMID: 22855152 DOI: 10.1007/s12094-012-0859-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
177 Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S. Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy 2012;4:291-304. [PMID: 22401635 DOI: 10.2217/imt.11.178] [Cited by in Crossref: 52] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
178 Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T, Ohta T. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Oncol Rep 2012;28:777-84. [PMID: 22751903 DOI: 10.3892/or.2012.1885] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
179 Bahl A, Bakhshi S. Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package. Indian J Pediatr 2012;79:1617-22. [PMID: 22544675 DOI: 10.1007/s12098-012-0759-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
180 Ji B, Liu Y, Zhang P, Wang Y, Wang G. COX-2 expression and tumor angiogenesis in thyroid carcinoma patients among northeast Chinese population-result of a single-center study. Int J Med Sci 2012;9:237-42. [PMID: 22577338 DOI: 10.7150/ijms.4173] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
181 Lichtenberger LM, Zhou Y, Jayaraman V, Doyen JR, O'Neil RG, Dial EJ, Volk DE, Gorenstein DG, Boggara MB, Krishnamoorti R. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine. Biochim Biophys Acta 2012;1821:994-1002. [PMID: 22521764 DOI: 10.1016/j.bbalip.2012.04.002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 7.6] [Reference Citation Analysis]
182 Moore AE, Young LE, Dixon DA. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev. 2011;30:419-435. [PMID: 22005950 DOI: 10.1007/s10555-011-9300-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
183 Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van de Velde CJ, Fodde R, Liefers GJ. Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 2012;106:1564-70. [PMID: 22454078 DOI: 10.1038/bjc.2012.101] [Cited by in Crossref: 107] [Cited by in F6Publishing: 115] [Article Influence: 10.7] [Reference Citation Analysis]
184 Kim B, Giardiello FM. Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol. 2011;25:607-622. [PMID: 22122775 DOI: 10.1016/j.bpg.2011.08.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
185 Menter DG, Dubois RN. Prostaglandins in cancer cell adhesion, migration, and invasion. Int J Cell Biol 2012;2012:723419. [PMID: 22505934 DOI: 10.1155/2012/723419] [Cited by in Crossref: 51] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
186 Kuratnik A, Senapati VE, Verma R, Mellone BG, Vella AT, Giardina C. Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest. Biochem Pharmacol 2012;83:1217-28. [PMID: 22306067 DOI: 10.1016/j.bcp.2012.01.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
187 Chan E, Lafleur B, Rothenberg ML, Merchant N, Lockhart AC, Trivedi B, Chung CH, Coffey RJ, Berlin JD. Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer. Am J Clin Oncol 2011;34:581-6. [PMID: 21217396 DOI: 10.1097/COC.0b013e3181fe46a1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
188 Janakiram NB, Rao CV. Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors. For Immunopathol Dis Therap 2012;3:155-67. [PMID: 23678395 DOI: 10.1615/ForumImmunDisTher.2012006186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
189 Ali R, Toh HC, Chia WK; ASCOLT Trial Investigators. The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial. Trials 2011;12:261. [PMID: 22168568 DOI: 10.1186/1745-6215-12-261] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
190 Zampeli E, Karamanolis G, Morfopoulos G, Xirouchakis E, Kalampoki V, Michopoulos S, Savva S, Tzias V, Zouboulis-Vafiadis I, Kamberoglou D. Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter? Dig Dis Sci. 2012;57:1190-1196. [PMID: 22147251 DOI: 10.1007/s10620-011-1990-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
191 Fitzgerald DW, Bezak K, Ocheretina O, Riviere C, Wright TC, Milne GL, Zhou XK, Du B, Subbaramaiah K, Byrt E. The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels. Cancer Prev Res (Phila). 2012;5:34-40. [PMID: 22135046 DOI: 10.1158/1940-6207.capr-11-0496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
192 Wójcik M, Ramadori P, Blaschke M, Sultan S, Khan S, Malik IA, Naz N, Martius G, Ramadori G, Schultze FC. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol. 2012;137:217-233. [PMID: 22131058 DOI: 10.1007/s00418-011-0889-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
193 Zhong B, Cai X, Chennamaneni S, Yi X, Liu L, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation. Eur J Med Chem. 2012;47:432-444. [PMID: 22119125 DOI: 10.1016/j.ejmech.2011.11.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
194 Zhang L, Wu YD, Li P, Tu J, Niu YL, Xu CM, Zhang ST. Effects of cyclooxygenase-2 on human esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(41): 4572-4580 [PMID: 22147962 DOI: 10.3748/wjg.v17.i41.4572] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
195 Weidenaar AC, ter Elst A, Kampen KR, Meeuwsen-de Boer TG, de Jonge HJ, Scherpen FJ, den Dunnen WF, Kamps WA, de Bont ES. Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling. Br J Cancer. 2011;105:1856-1863. [PMID: 22045186 DOI: 10.1038/bjc.2011.460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
196 Moshal KS, Ferri-Lagneau KF, Haider J, Pardhanani P, Leung T. Discriminating different cancer cells using a zebrafish in vivo assay. Cancers (Basel) 2011;3:4102-13. [PMID: 24213127 DOI: 10.3390/cancers3044102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
197 Kim TH, Jeong YI, Jin SG, Pei J, Jung TY, Moon KS, Kim IY, Kang SS, Jung S. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. Int J Nanomedicine 2011;6:2621-31. [PMID: 22114493 DOI: 10.2147/IJN.S19497] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
198 Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011;11:761-74. [PMID: 21993244 DOI: 10.1038/nrc3106] [Cited by in Crossref: 1043] [Cited by in F6Publishing: 1023] [Article Influence: 94.8] [Reference Citation Analysis]
199 Gentile LB, Piva B, Diaz BL. Hypertonic stress induces VEGF production in human colon cancer cell line Caco-2: inhibitory role of autocrine PGE₂. PLoS One 2011;6:e25193. [PMID: 21980393 DOI: 10.1371/journal.pone.0025193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
200 Marshall B, Zhang M, Atherton SS. The effect of murine cytomegalovirus IE-3 specific shRNA is dependent on intragenic target site due to multiple transcription initiation sites. Herpesviridae 2011;2:9. [PMID: 21923934 DOI: 10.1186/2042-4280-2-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
201 Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, Dubinett SM. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron 2012;5:5-18. [PMID: 21922183 DOI: 10.1007/s12307-011-0089-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
202 Valcárcel M, Mendoza L, Hernández JJ, Carrascal T, Salado C, Crende O, Vidal-Vanaclocha F. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. J Transl Med 2011;9:142. [PMID: 21867538 DOI: 10.1186/1479-5876-9-142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
203 Fan F, Schimming A, Jaeger D, Podar K. Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012;2012:281261. [PMID: 21876693 DOI: 10.1155/2012/281261] [Cited by in Crossref: 53] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
204 Chi Y, Min J, Jasmin JF, Lisanti MP, Chang YT, Schuster VL. Development of a high-affinity inhibitor of the prostaglandin transporter. J Pharmacol Exp Ther 2011;339:633-41. [PMID: 21849625 DOI: 10.1124/jpet.111.181354] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
205 Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16:4567-4598. [PMID: 21642934 DOI: 10.3390/molecules16064567] [Cited by in Crossref: 385] [Cited by in F6Publishing: 383] [Article Influence: 35.0] [Reference Citation Analysis]
206 Zhou LH, Wang Y, Fan ZZ, Wu Q, Liu X, Ci SJ, Li Q. Tan IIA inhibits COX-2-regulated VEGF expression in human colon cancer HCT-116 cells. Shijie Huaren Xiaohua Zazhi 2011; 19(15): 1561-1567 [DOI: 10.11569/wcjd.v19.i15.1561] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
207 Catalano RD, Wilson MR, Boddy SC, McKinlay AT, Sales KJ, Jabbour HN. Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth. PLoS One 2011;6:e19209. [PMID: 21589857 DOI: 10.1371/journal.pone.0019209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
208 Walker JD, Sehgal I, Kousoulas KG. Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice. J Virol 2011;85:7363-71. [PMID: 21543507 DOI: 10.1128/JVI.00098-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
209 Kim BH, Kim CI, Chang HS, Choe MS, Jung HR, Kim DY, Park CH. Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer? Korean J Urol 2011;52:253-9. [PMID: 21556211 DOI: 10.4111/kju.2011.52.4.253] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
210 Ericsson AC, Myles M, Davis W, Ma L, Lewis M, Maggio-Price L, Franklin C. Noninvasive detection of inflammation-associated colon cancer in a mouse model. Neoplasia 2010;12:1054-65. [PMID: 21170269 DOI: 10.1593/neo.10940] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
211 Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol. 2011;106:1340-1350. [PMID: 21407185 DOI: 10.1038/ajg.2011.38ajg201138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
212 Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol. 2011;106:1340-1350. [PMID: 21407185 DOI: 10.1038/ajg.2011.38] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 9.1] [Reference Citation Analysis]
213 Zhao Q, Wang C, Zhu J, Wang L, Dong S, Zhang G, Tian J. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study. J Exp Clin Cancer Res 2011;30:26. [PMID: 21375766 DOI: 10.1186/1756-9966-30-26] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
214 Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-411. [PMID: 21036793 DOI: 10.1136/gut.2010.217182] [Cited by in Crossref: 388] [Cited by in F6Publishing: 403] [Article Influence: 35.3] [Reference Citation Analysis]
215 Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, Kakuguchi W, Kuroshima T, Kondo M, Akino T, Totsuka Y, Shindoh M, Higashino F, Hida K. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium. Br J Cancer. 2011;104:819-829. [PMID: 21285980 DOI: 10.1038/bjc.2011.20] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 6.4] [Reference Citation Analysis]
216 Li W, Wang J, Jiang HR, Xu XL, Zhang J, Liu ML, Zhai LY. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo. Int J Mol Sci 2011;12:668-81. [PMID: 21340007 DOI: 10.3390/ijms12010668] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
217 Pozzi A, Zent R. Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products. Wiley Interdiscip Rev Syst Biol Med 2009;1:254-72. [PMID: 20835995 DOI: 10.1002/wsbm.7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
218 Liu JL, Liang Y, Wang ZN, Zhou X, Xing LL. Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis. World J Gastroenterol 2010; 16(43): 5510-5517 [PMID: 21086572 DOI: 10.3748/wjg.v16.i43.5510] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
219 Xin D, Rendon BE, Zhao M, Winner M, McGhee Coleman A, Mitchell RA. The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms. Mol Cancer Res 2010;8:1601-9. [PMID: 21071513 DOI: 10.1158/1541-7786.MCR-10-0101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
220 Urbanska AM, Paul A, Bhathena J, Prakash S. Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation. Int J Inflam. 2010;2010:894972. [PMID: 21188222 DOI: 10.4061/2010/894972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
221 Han YD, Hong YK, Kang JG, Choi YJ, Park CH. Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis. J Korean Soc Coloproctol. 2010;26:339-346. [PMID: 21152137 DOI: 10.3393/jksc.2010.26.5.339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
222 Soroceanu L, Cobbs CS. Is HCMV a tumor promoter? Virus Res. 2011;157:193-203. [PMID: 21036194 DOI: 10.1016/j.virusres.2010.10.026] [Cited by in Crossref: 124] [Cited by in F6Publishing: 124] [Article Influence: 10.3] [Reference Citation Analysis]
223 Matsuoka T, Adair JE, Lih FB, Hsi LC, Rubino M, Eling TE, Tomer KB, Yashiro M, Hirakawa K, Olden K, Roberts JD. Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice. Br J Cancer 2010;103:1182-91. [PMID: 20842125 DOI: 10.1038/sj.bjc.6605881] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
224 Compare D, Nardone O, Nardone G. Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract. Pharmaceuticals (Basel) 2010;3:2495-516. [PMID: 27713364 DOI: 10.3390/ph3082495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
225 Suesskind D, Paulsen F, Buchgeister M, Spitzer B, Rohrbach JM, Bartz-Schmidt KU, Spitzer MS. Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas. Acta Ophthalmol 2010;88:582-7. [PMID: 19432844 DOI: 10.1111/j.1755-3768.2008.01475.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
226 Miao LJ, Shiraishi R, Fujise T, Kakimoto T, Iwakiri R, Fujimoto K, Shi RH, Li XL. Mofezolac suppresses beef tallow-promoted colon carcinogenesis in rats. Shijie Huaren Xiaohua Zazhi 2010; 18(17): 1767-1772 [DOI: 10.11569/wcjd.v18.i17.1767] [Reference Citation Analysis]
227 Hsu A, Bray TM, Ho E. Anti-inflammatory activity of soy and tea in prostate cancer prevention. Exp Biol Med (Maywood) 2010;235:659-67. [PMID: 20511670 DOI: 10.1258/ebm.2010.009335] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
228 Strillacci A, Griffoni C, Valerii MC, Lazzarini G, Tomasi V, Spisni E. RNAi-based strategies for cyclooxygenase-2 inhibition in cancer. J Biomed Biotechnol 2010;2010:828045. [PMID: 20625420 DOI: 10.1155/2010/828045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
229 Mizushima T. Molecular Mechanism for Various Pharmacological Activities of NSAIDS. Pharmaceuticals (Basel) 2010;3:1614-36. [PMID: 27713320 DOI: 10.3390/ph3051614] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
230 Khabar KS. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci. 2010;67:2937-2955. [PMID: 20495997 DOI: 10.1007/s00018-010-0383-x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 110] [Article Influence: 8.8] [Reference Citation Analysis]
231 Conti A, Gulì C, La Torre D, Tomasello C, Angileri FF, Aguennouz M. Role of inflammation and oxidative stress mediators in gliomas. Cancers (Basel) 2010;2:693-712. [PMID: 24281089 DOI: 10.3390/cancers2020693] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
232 Latifah SY, Armania N, Tze TH, Azhar Y, Nordiana AH, Norazalina S, Hairuszah I, Saidi M, Maznah I. Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats. Nutr J 2010;9:16. [PMID: 20346115 DOI: 10.1186/1475-2891-9-16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
233 Sobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol. 2010;2010:215158. [PMID: 20339581 DOI: 10.1155/2010/215158] [Cited by in Crossref: 234] [Cited by in F6Publishing: 275] [Article Influence: 19.5] [Reference Citation Analysis]
234 Tsuchida A, Itoi T. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction. World J Gastrointest Oncol 2010; 2(3): 130-135 [PMID: 21160820 DOI: 10.4251/wjgo.v2.i3.130] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
235 Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 2010;3:149-166. [PMID: 21209781 DOI: 10.1007/s12307-010-0038-3] [Cited by in Crossref: 108] [Cited by in F6Publishing: 131] [Article Influence: 9.0] [Reference Citation Analysis]
236 Buttar NS, DeMars CJ, Lomberk G, Rizvi S, Bonilla-Velez J, Achra S, Rashtak S, Wang KK, Fernandez-Zapico ME, Urrutia R. Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis. J Biol Chem 2010;285:11433-44. [PMID: 20154088 DOI: 10.1074/jbc.M109.077065] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
237 Khunnarong J, Tangjitgamol S, Manusirivithaya S, Pataradool K, Thavaramara T, Leelahakorn S. Expression of Cyclooxygenase-1 and 2 in Epithelial Ovarian Cancer: A Clinicopathologic Study. World J Oncol 2010;1:19-27. [PMID: 29147175 DOI: 10.4021/wjon2010.02.190w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
238 Yashiro M, Hirakawa K. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 2010;3:127-35. [PMID: 21209779 DOI: 10.1007/s12307-010-0036-5] [Cited by in F6Publishing: 65] [Reference Citation Analysis]
239 Keightley MC, Brown P, Jabbour HN, Sales KJ. F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2. BMC Cell Biol 2010;11:8. [PMID: 20092633 DOI: 10.1186/1471-2121-11-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
240 Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147-156. [PMID: 20075923 DOI: 10.1038/nrc2789] [Cited by in Crossref: 666] [Cited by in F6Publishing: 670] [Article Influence: 55.5] [Reference Citation Analysis]
241 Duhoux FP, Machiels JP. Antivascular therapy for epithelial ovarian cancer. J Oncol. 2010;2010:372547. [PMID: 20072701 DOI: 10.1155/2010/372547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
242 Kamei D, Murakami M, Sasaki Y, Nakatani Y, Majima M, Ishikawa Y, Ishii T, Uematsu S, Akira S, Hara S, Kudo I. Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis. Biochem J 2009;425:361-71. [PMID: 19845504 DOI: 10.1042/BJ20090045] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
243 Jung JH, Chae YS, Moon JH, Kang BW, Kim JG, Sohn SK, Park JY, Lee MH, Park HY. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. J Cancer Res Clin Oncol 2010;136:685-94. [PMID: 19890662 DOI: 10.1007/s00432-009-0707-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
244 Nagendraprabhu P, Sudhandiran G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 2011;29:207-24. [PMID: 19876598 DOI: 10.1007/s10637-009-9342-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 8.5] [Reference Citation Analysis]
245 Kuo CH, Hu HM, Tsai PY, Wu IC, Yang SF, Chang LL, Wang JY, Jan CM, Wang WM, Wu DC. Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol 2009; 15(39): 4907-4914 [PMID: 19842220 DOI: 10.3748/wjg.15.4907] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
246 Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila) 2009;2:957-65. [PMID: 19843689 DOI: 10.1158/1940-6207.CAPR-09-0093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
247 Fosslien E. The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curved structures. Dose Response 2009;7:307-31. [PMID: 20011651 DOI: 10.2203/dose-response.09-013.Fosslien] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
248 Alzabin S, Pyarajan S, Yee H, Kiefer F, Suzuki A, Burakoff S, Sawasdikosol S. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother 2010;59:419-29. [PMID: 19787351 DOI: 10.1007/s00262-009-0761-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
249 Fredenburgh LE, Ma J, Perrella MA. Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility. Trends Cardiovasc Med 2009;19:31-7. [PMID: 19577709 DOI: 10.1016/j.tcm.2009.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
250 Omi Y, Shibata N, Okamoto T, Obara T, Kobayashi M. Immunohistochemical demonstration of membrane-bound prostaglandin E2 synthase-1 in papillary thyroid carcinoma. Acta Histochem Cytochem 2009;42:105-9. [PMID: 19759871 DOI: 10.1267/ahc.09014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
251 Wang Q, Takei Y, Kobayashi O, Osada T, Watanabe S. Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells. J Clin Biochem Nutr. 2009;45:163-170. [PMID: 19794924 DOI: 10.3164/jcbn.09-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
252 Yung YC, Chae J, Buehler MJ, Hunter CP, Mooney DJ. Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells. Proc Natl Acad Sci U S A 2009;106:15279-84. [PMID: 19706407 DOI: 10.1073/pnas.0905891106] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
253 Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 2009;302:649-58. [PMID: 19671906 DOI: 10.1001/jama.2009.1112] [Cited by in Crossref: 391] [Cited by in F6Publishing: 377] [Article Influence: 30.1] [Reference Citation Analysis]
254 Moody TW, Switzer C, Santana-Flores W, Ridnour LA, Berna M, Thill M, Jensen RT, Sparatore A, Del Soldato P, Yeh GC, Roberts DD, Giaccone G, Wink DA. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. Lung Cancer 2010;68:154-60. [PMID: 19628293 DOI: 10.1016/j.lungcan.2009.06.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
255 Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 2009;486:95-102. [PMID: 19514131 DOI: 10.1016/j.abb.2009.01.018] [Cited by in Crossref: 307] [Cited by in F6Publishing: 288] [Article Influence: 23.6] [Reference Citation Analysis]
256 Wallace AE, Sales KJ, Catalano RD, Anderson RA, Williams AR, Wilson MR, Schwarze J, Wang H, Rossi AG, Jabbour HN. Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma. Cancer Res 2009;69:5726-33. [PMID: 19549892 DOI: 10.1158/0008-5472.CAN-09-0390] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
257 Kalén M, Wallgard E, Asker N, Nasevicius A, Athley E, Billgren E, Larson JD, Wadman SA, Norseng E, Clark KJ, He L, Karlsson-Lindahl L, Häger AK, Weber H, Augustin H, Samuelsson T, Kemmet CK, Utesch CM, Essner JJ, Hackett PB, Hellström M. Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. Chem Biol 2009;16:432-41. [PMID: 19389629 DOI: 10.1016/j.chembiol.2009.02.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
258 Hu HM, Kuo CH, Lee CH, Wu IC, Lee KW, Lee JM, Goan YG, Chou SH, Kao EL, Wu MT. Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol. 2009;9:37. [PMID: 19463183 DOI: 10.1186/1471-230x-9-37] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
259 Czembirek C, Eder-Czembirek C, Erovic BM, Turhani D, Spittler A, Selzer E, Pötter R, Thurnher D. The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells. Strahlenther Onkol. 2009;185:310-317. [PMID: 19440670 DOI: 10.1007/s00066-009-1929-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
260 Seo T, Tatsuguchi A, Shinji S, Yonezawa M, Mitsui K, Tanaka S, Fujimori S, Gudis K, Fukuda Y, Sakamoto C. Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients. Virchows Arch. 2009;454:667-676. [PMID: 19412621 DOI: 10.1007/s00428-009-0777-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
261 Barry M, Cahill RA, Roche-Nagle G, Neilan TG, Treumann A, Harmey JH, Bouchier-Hayes DJ. Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer. Ir J Med Sci. 2009;178:201-208. [PMID: 19340516 DOI: 10.1007/s11845-009-0335-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
262 McConnell BB, Yang VW. The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep. 2009;5:69-74. [PMID: 19756239 DOI: 10.1007/s11888-009-0011-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
263 Zhang MZ, Xu J, Yao B, Yin H, Cai Q, Shrubsole MJ, Chen X, Kon V, Zheng W, Pozzi A, Harris RC. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest 2009;119:876-85. [PMID: 19307727 DOI: 10.1172/JCI37398] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 6.1] [Reference Citation Analysis]
264 Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) 2008;1:241-9. [PMID: 19138967 DOI: 10.1158/1940-6207.CAPR-08-0055] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
265 Jang TJ, Ji YS, Jung KH. Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas. Yonsei Med J. 2008;49:917-922. [PMID: 19108014 DOI: 10.3349/ymj.2008.49.6.917] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
266 Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci U S A 2009;106:3372-7. [PMID: 19218449 DOI: 10.1073/pnas.0813306106] [Cited by in Crossref: 138] [Cited by in F6Publishing: 160] [Article Influence: 10.6] [Reference Citation Analysis]
267 Lee SH, Bahn JH, Choi CK, Whitlock NC, English AE, Safe S, Baek SJ. ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells. Mol Cancer Ther 2008;7:3739-50. [PMID: 19074849 DOI: 10.1158/1535-7163.MCT-08-0548] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
268 Gadgeel SM, Wozniak A, Ruckdeschel JC, Heilbrun LK, Venkatramanamoorthy R, Chaplen RA, Kraut MJ, Kalemkerian GP. Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer. J Thorac Oncol 2008;3:1293-300. [PMID: 18978565 DOI: 10.1097/JTO.0b013e31818b194e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
269 Stasinopoulos I, Mori N, Bhujwalla ZM. The malignant phenotype of breast cancer cells is reduced by COX-2 silencing. Neoplasia 2008;10:1163-9. [PMID: 18953425 DOI: 10.1593/neo.08568] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
270 Cao B, Chen XP, Zhu P, Ding L, Guan J, Shi ZL. Inhibitory effect of interferon-α-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 2008; 14(44): 6802-6807 [PMID: 19058305 DOI: 10.3748/wjg.14.6802] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
271 Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers. J Gastrointest Cancer. 2007;38:78-82. [PMID: 19031117 DOI: 10.1007/s12029-008-9035-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
272 Li W, Xu RJ, Lin ZY, Zhuo GC, Zhang HH. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor. Med Oncol 2009;26:170-7. [PMID: 18988002 DOI: 10.1007/s12032-008-9104-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
273 Sansone P, Piazzi G, Paterini P, Strillacci A, Ceccarelli C, Minni F, Biasco G, Chieco P, Bonafè M. Cyclooxygenase-2/carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J Cell Mol Med 2009;13:3876-87. [PMID: 19017360 DOI: 10.1111/j.1582-4934.2008.00580.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
274 Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 2008;57:1509-17. [PMID: 18596194 DOI: 10.1136/gut.2008.152496] [Cited by in Crossref: 123] [Cited by in F6Publishing: 121] [Article Influence: 8.8] [Reference Citation Analysis]
275 Rodriguez NI, Hoots WK, Koshkina NV, Morales-Arias JA, Arndt CA, Inwards CY, Hawkins DS, Munsell MF, Kleinerman ES. COX-2 expression correlates with survival in patients with osteosarcoma lung metastases. J Pediatr Hematol Oncol 2008;30:507-12. [PMID: 18797196 DOI: 10.1097/MPH.0b013e31816e238c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
276 Valcárcel M, Arteta B, Jaureguibeitia A, Lopategi A, Martínez I, Mendoza L, Muruzabal FJ, Salado C, Vidal-Vanaclocha F. Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis. J Transl Med. 2008;6:57. [PMID: 18844982 DOI: 10.1186/1479-5876-6-57] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
277 Subbaramaiah K, Benezra R, Hudis C, Dannenberg AJ. Cyclooxygenase-2-derived prostaglandin E2 stimulates Id-1 transcription. J Biol Chem 2008;283:33955-68. [PMID: 18842581 DOI: 10.1074/jbc.M805490200] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
278 Kanies CL, Smith JJ, Kis C, Schmidt C, Levy S, Khabar KS, Morrow J, Deane N, Dixon DA, Beauchamp RD. Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res. 2008;6:1124-1136. [PMID: 18644977 DOI: 10.1158/1541-7786.mcr-07-2095] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
279 Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton AM. Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function. Breast Cancer Res Treat 2009;117:235-42. [PMID: 18792778 DOI: 10.1007/s10549-008-0180-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
280 Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck 2008;30:946-63. [PMID: 18446839 DOI: 10.1002/hed.20833] [Cited by in Crossref: 198] [Cited by in F6Publishing: 208] [Article Influence: 14.1] [Reference Citation Analysis]
281 Chu PH, Yeh LK, Lin HC, Jung SM, Ma DH, Wang IJ, Wu HH, Shiu TF, Chen J. Deletion of the FHL2 gene attenuating neovascularization after corneal injury. Invest Ophthalmol Vis Sci 2008;49:5314-8. [PMID: 18708619 DOI: 10.1167/iovs.08-2209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
282 Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J. 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer. Cancer Res. 2008;68:5040-5048. [PMID: 18593902 DOI: 10.1158/0008-5472.CAN-07-6575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
283 Hassan MH, Eyzaguirre E, Arafa HM, Hamada FM, Salama SA, Al-Hendy A. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol 2008;199:156.e1-8. [PMID: 18468574 DOI: 10.1016/j.ajog.2008.02.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
284 Oshio H, Abe T, Onogawa T, Ohtsuka H, Sato T, Ii T, Fukase K, Muto M, Katayose Y, Oikawa M, Rikiyama T, Egawa S, Unno M. Peroxisome proliferator-activated receptor α activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines. J Gastroenterol 2008;43:538-49. [DOI: 10.1007/s00535-008-2188-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
285 Zrieki A, Farinotti R, Buyse M. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res 2008;25:1991-2001. [PMID: 18581209 DOI: 10.1007/s11095-008-9596-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
286 Tani T, Ayuzawa R, Takagi T, Kanehira T, Maurya DK, Tamura M. Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells. Mol Cell Biochem 2008;315:185-93. [PMID: 18543083 DOI: 10.1007/s11010-008-9806-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
287 Kim SW, Jang TJ, Jung KH, Suh JI. Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats. Yonsei Med J 2007;48:1020-7. [PMID: 18159596 DOI: 10.3349/ymj.2007.48.6.1020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
288 Wang S, Wu J. Biological effects of HBV X protein on hepatocellular carcinogenesis in association with cellular factors. Virol Sin 2008;23:146-51. [DOI: 10.1007/s12250-008-2952-9] [Reference Citation Analysis]
289 Houssier M, Raoul W, Lavalette S, Keller N, Guillonneau X, Baragatti B, Jonet L, Jeanny JC, Behar-Cohen F, Coceani F, Scherman D, Lachapelle P, Ong H, Chemtob S, Sennlaub F. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Med 2008;5:e39. [PMID: 18288886 DOI: 10.1371/journal.pmed.0050039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
290 Lee KJ, Jung YS, Kim WH, Yoon TI, Joo HJ, Soh EY. Cyclooxygenase-2 expression in human thyroid disease. J Endocrinol Invest 2008;31:111-8. [PMID: 18362501 DOI: 10.1007/BF03345576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
291 Janakiram NB, Indranie C, Malisetty SV, Jagan P, Steele VE, Rao CV. Chemoprevention of colon carcinogenesis by oleanolic acid and its analog in male F344 rats and modulation of COX-2 and apoptosis in human colon HT-29 cancer cells. Pharm Res 2008;25:2151-7. [PMID: 18408893 DOI: 10.1007/s11095-008-9582-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
292 Park EK, Bae SM, Kwak SY, Lee SJ, Kim YW, Han CH, Cho HJ, Kim KT, Kim YJ, Kim HJ, Ahn WS. Photodynamic therapy with recombinant adenovirus AdmIL-12 enhances anti-tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model. Immunology 2008;124:461-8. [PMID: 18397271 DOI: 10.1111/j.1365-2567.2007.02797.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
293 Markowitz SD. Colorectal neoplasia goes with the flow: prostaglandin transport and termination. Cancer Prev Res (Phila) 2008;1:77-9. [PMID: 19138938 DOI: 10.1158/1940-6207.CAPR-08-0009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
294 Feng Y, Neale JR, Doll MA, Hein DW. Chemoprevention of arylamine-induced colorectal aberrant crypts. Exp Biol Med (Maywood) 2008;233:71-5. [PMID: 18156308 DOI: 10.3181/0707-RM-180] [Reference Citation Analysis]
295 Misra S, Obeid LM, Hannun YA, Minamisawa S, Berger FG, Markwald RR, Toole BP, Ghatak S. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem 2008;283:14335-44. [PMID: 18326857 DOI: 10.1074/jbc.M703811200] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
296 de Heer P, Sandel MH, Guertens G, de Boeck G, Koudijs MM, Nagelkerke JF, Junggeburt JM, de Bruijn EA, van de Velde CJ, Kuppen PJ. Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer. Cancer Chemother Pharmacol. 2008;62:811-819. [PMID: 18247029 DOI: 10.1007/s00280-007-0668-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
297 Chen L, He Y, Huang H, Liao H, Wei W. Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study. Med Oncol 2008;25:161-71. [PMID: 18172786 DOI: 10.1007/s12032-007-9015-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
298 Janakiram NB, Rao CV. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol Sin 2008;29:1-20. [PMID: 18158862 DOI: 10.1111/j.1745-7254.2008.00742.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
299 Xin B, Yokoyama Y, Shigeto T, Mizunuma H. Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers. Pathol Oncol Res 2007;13:365-9. [PMID: 18158574 DOI: 10.1007/BF02940318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
300 Dianzani C, Brucato L, Gallicchio M, Rosa AC, Collino M, Fantozzi R. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br J Pharmacol. 2008;153:1153-1161. [PMID: 18084316 DOI: 10.1038/sj.bjp.0707636] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
301 Gallicchio M, Rosa AC, Dianzani C, Brucato L, Benetti E, Collino M, Fantozzi R. Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol. 2008;153:870-878. [PMID: 18084318 DOI: 10.1038/sj.bjp.0707634] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
302 Hayslip J, Chaudhary U, Green M, Meyer M, Dunder S, Sherman C, Salzer S, Kraft A, Montero AJ. Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial. BMC Cancer 2007;7:221. [PMID: 18053191 DOI: 10.1186/1471-2407-7-221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
303 Chen YC, Chen KT. Novel selective inhibitors of hydroxyxanthone derivatives for human cyclooxygenase-2. Acta Pharmacol Sin 2007;28:2027-32. [PMID: 18031619 DOI: 10.1111/j.1745-7254.2007.00663.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
304 Lu L, Wei L, Peng G, Mu Y, Wu K, Kang L, Yan X, Zhu Y, Wu J. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 2008;371:61-70. [PMID: 17964630 DOI: 10.1016/j.virol.2007.09.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
305 Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 2007;117:2506-16. [PMID: 17710232 DOI: 10.1172/JCI31123] [Cited by in Crossref: 154] [Cited by in F6Publishing: 136] [Article Influence: 10.3] [Reference Citation Analysis]
306 Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008;134:21-28. [PMID: 18005960 DOI: 10.1053/j.gastro.2007.09.035] [Cited by in Crossref: 170] [Cited by in F6Publishing: 156] [Article Influence: 11.3] [Reference Citation Analysis]
307 Qualtrough D, Kaidi A, Chell S, Jabbour HN, Williams AC, Paraskeva C. Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells. Int J Cancer 2007;121:734-40. [PMID: 17437271 DOI: 10.1002/ijc.22755] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
308 Chen X, Aravindakshan J, Yang Y, Sairam MR. Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor. Neoplasia 2007;9:521-31. [PMID: 17603635 DOI: 10.1593/neo.07238] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
309 Xu K, Shu HK. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res 2007;67:6121-9. [PMID: 17616668 DOI: 10.1158/0008-5472.CAN-07-0141] [Cited by in Crossref: 97] [Cited by in F6Publishing: 84] [Article Influence: 6.5] [Reference Citation Analysis]
310 Ali MA, Choy H, Habib AA, Saha D. SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor. Neoplasia 2007;9:370-81. [PMID: 17534442 DOI: 10.1593/neo.07136] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
311 Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl) 2007;85:1175-86. [PMID: 17589818 DOI: 10.1007/s00109-007-0221-2] [Cited by in Crossref: 159] [Cited by in F6Publishing: 159] [Article Influence: 10.6] [Reference Citation Analysis]
312 Hong KH, Cho ML, Min SY, Shin YJ, Yoo SA, Choi JJ, Kim WU, Song SW, Cho CS. Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol 2007;147:573-9. [PMID: 17302909 DOI: 10.1111/j.1365-2249.2006.03295.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
313 Yoshikawa R, Fujiwara Y, Koishi K, Kojima S, Matsumoto T, Yanagi H, Yamamura T, Hashimoto-Tamaoki T, Nishigami T, Tsujimura T. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. World J Gastroenterol 2007; 13(16): 2283-2288 [PMID: 17511025 DOI: 10.3748/wjg.v13.i16.2283] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
314 El-Rayes BF, Zalupski MM, Manza SG, Rusin B, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Shields AF, Philip PA. Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer. Cancer Chemother Pharmacol 2008;61:283-9. [PMID: 17429629 DOI: 10.1007/s00280-007-0472-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
315 Boosani CS, Mannam AP, Cosgrove D, Silva R, Hodivala-Dilke KM, Keshamouni VG, Sudhakar A. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Blood 2007;110:1168-77. [PMID: 17426256 DOI: 10.1182/blood-2007-01-066282] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
316 Nishida T, Yabe Y, Fu HY, Hayashi Y, Asahi K, Eguchi H, Tsuji S, Tsujii M, Hayashi N, Kawano S. Geranylgeranylacetone induces cyclooxygenase-2 expression in cultured rat gastric epithelial cells through NF-kappaB. Dig Dis Sci. 2007;52:1890-1896. [PMID: 17404846 DOI: 10.1007/s10620-006-9661-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
317 Li CJ, Wei PK. Research progress on gene expression correlated with gastric cancer cell proliferation. Shijie Huaren Xiaohua Zazhi 2007; 15(9): 975-979 [DOI: 10.11569/wcjd.v15.i9.975] [Reference Citation Analysis]
318 Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res. 2006;8:R69. [PMID: 17156488 DOI: 10.1186/bcr1626] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 4.5] [Reference Citation Analysis]
319 Raspollini MR, Taddei GL. Cyclooxygenase-2: a novel target in human solid tumors. Curr Oncol Rep 2007;9:96-101. [PMID: 17288873 DOI: 10.1007/s11912-007-0004-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
320 Xiao WM, Shi RH, Ding YB, Gong WJ, Ding YL, Xue Y. Expression of epidermal growth factor receptor and cyclooxygenase-2 and their correlations in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2007; 15(2): 123-128 [DOI: 10.11569/wcjd.v15.i2.123] [Reference Citation Analysis]
321 Lee YJ, Lee HR, Nam CM, Hwang UK, Jee SH. White blood cell count and the risk of colon cancer. Yonsei Med J 2006;47:646-56. [PMID: 17066508 DOI: 10.3349/ymj.2006.47.5.646] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
322 Ouyang W, Zhang D, Ma Q, Li J, Huang C. Cyclooxygenase-2 induction by arsenite through the IKKbeta/NFkappaB pathway exerts an antiapoptotic effect in mouse epidermal Cl41 cells. Environ Health Perspect 2007;115:513-8. [PMID: 17450217 DOI: 10.1289/ehp.9588] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
323 Pazirandeh S, Khettry U, Gordon FD, Resnick RH, Murray JE, Sheth SG. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States. Dig Dis Sci 2007;52:220-7. [PMID: 17160481 DOI: 10.1007/s10620-006-9184-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
324 Bifulco M, Laezza C, Pisanti S, Gazzerro P. Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 2006;148:123-35. [PMID: 16501583 DOI: 10.1038/sj.bjp.0706632] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 6.1] [Reference Citation Analysis]
325 Buxant F, Devreker F, Noël J. The Effect of a Cyclooxygenase-2 Inhibitor on Proliferating Activity in Breast Cancer: First Results. Breast Care 2006;1:320-3. [DOI: 10.1159/000095503] [Reference Citation Analysis]
326 Azzoni C, Bottarelli L, Campanini N, Di Cola G, Bader G, Mazzeo A, Salvemini C, Morari S, Di Mauro D, Donadei E. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis. 2007;22:115-126. [PMID: 17021745 DOI: 10.1007/s00384-006-0093-x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.8] [Reference Citation Analysis]
327 Wadhwa P, Goswami AK, Joshi K, Sharma SK. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder. Int Urol Nephrol 2005;37:47-53. [PMID: 16132759 DOI: 10.1007/s11255-004-4699-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
328 Allison M, Garland C, Chlebowski R, Criqui M, Langer R, Wu L, Roy H, McTiernan A, Kuller L; Women's Health Initiative Investigators. The association between aspirin use and the incidence of colorectal cancer in women. Am J Epidemiol 2006;164:567-75. [PMID: 16847042 DOI: 10.1093/aje/kwj250] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
329 Tanaka S, Arii S. Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma. Int J Clin Oncol. 2006;11:82-89. [PMID: 16622743 DOI: 10.1007/s10147-006-0566-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
330 Timoshenko AV, Chakraborty C, Wagner GF, Lala PK. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer. 2006;94:1154-1163. [PMID: 16570043 DOI: 10.1038/sj.bjc.6603067] [Cited by in Crossref: 107] [Cited by in F6Publishing: 113] [Article Influence: 6.7] [Reference Citation Analysis]
331 Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol 2006; 12(32): 5113-5121 [PMID: 16937518 DOI: 10.3748/wjg.v12.i32.5113] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
332 Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 2007;22:36-44. [PMID: 16905765 DOI: 10.1093/humrep/del328] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
333 Cerezo L, Cárdenes H, Michael H. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications. Clin Transl Oncol 2006;8:231-41. [PMID: 16648098 DOI: 10.1007/BF02664933] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
334 Guariniello LD, Correa M, Jasiulionis MG, Machado J Jr, Silva JA Jr, Pesquero JB, Carneiro CR. Effects of transforming growth factor-beta in the development of inflammatory pseudotumour-like lesions in a murine model. Int J Exp Pathol 2006;87:185-95. [PMID: 16709227 DOI: 10.1111/j.1365-2613.2006.00471.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
335 Muthian G, Raikwar HP, Johnson C, Rajasingh J, Kalgutkar A, Marnett LJ, Bright JJ. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. J Clin Immunol 2006;26:73-85. [PMID: 16418805 DOI: 10.1007/s10875-006-8787-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
336 Hosono A, Yamaguchi U, Makimoto A, Endo M, Watanabe A, Shimoda T, Kaya M, Matsumura T, Sonobe H, Kusumi T, Yamaguchi T, Hasegawa T. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol 2007;60:410-4. [PMID: 16822878 DOI: 10.1136/jcp.2006.038828] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
337 Bhandari P, Bateman AC, Mehta RL, Stacey BS, Johnson P, Cree IA, Di Nicolantonio F, Patel P. Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer 2006;6:134. [PMID: 16712734 DOI: 10.1186/1471-2407-6-134] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
338 Hillinger S, Yang SC, Batra RK, Strieter RM, Weder W, Dubinett SM, Sharma S. CCL19 reduces tumour burden in a model of advanced lung cancer. Br J Cancer 2006;94:1029-34. [PMID: 16598185 DOI: 10.1038/sj.bjc.6603061] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
339 Tao KX, Zhang N, Wang GB, Wu XB. Effects of meloxicam on vascular endothelial growth factor and angiopoietin-2 expression in colon carcinoma cell line HT-29. Shijie Huaren Xiaohua Zazhi 2006; 14(13): 1277-1282 [DOI: 10.11569/wcjd.v14.i13.1277] [Reference Citation Analysis]
340 Fan XM, Jiang XH, Gu Q, Ching YP, He H, Xia HH, Lin MC, Chan AO, Yuen MF, Kung HF, Wong BC. Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells. Digestion 2006;73:75-83. [PMID: 16641552 DOI: 10.1159/000092747] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
341 Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006;203:941-951. [PMID: 16567391 DOI: 10.1084/jem.20052124] [Cited by in Crossref: 231] [Cited by in F6Publishing: 232] [Article Influence: 14.4] [Reference Citation Analysis]
342 Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: Underlying molecular and cellular mechanisms. World J Gastroenterol 2006; 12(11): 1671-1680 [PMID: 16586533 DOI: 10.3748/wjg.v12.i11.1671] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
343 Park JM, Choi JE, Chae MH, Lee WK, Cha SI, Son JW, Kim CH, Kam S, Kang YM, Jung TH, Park JY. Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer 2006;6:70. [PMID: 16542464 DOI: 10.1186/1471-2407-6-70] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
344 Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience. World J Gastroenterol 2006; 12(9): 1336-1345 [PMID: 16552798 DOI: 10.3748/wjg.v12.i9.1336] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
345 Perrone G, Santini D, Verzì A, Vincenzi B, Borzomati D, Vecchio F, Coppola R, Antinori A, Magistrelli P, Tonini G. COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables. J Clin Pathol. 2006;59:492-496. [PMID: 16489179 DOI: 10.1136/jcp.2005.030098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
346 Alvarez-Soria MA, Largo R, Santillana J, Sánchez-Pernaute O, Calvo E, Hernández M, Egido J, Herrero-Beaumont G. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis 2006;65:998-1005. [PMID: 16476713 DOI: 10.1136/ard.2005.046920] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
347 Liu J, Yu HG, Yu JP, Wang XL, Zhou XD, Luo HS. Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol. 2005;22:389-397. [PMID: 16260857 DOI: 10.1385/MO:22:4:389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
348 Liu J, Yu HG, Yu JP, Wang XL, Zhou XD, Luo HS. Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis. Med Oncol. 2005;22:389-397. [PMID: 16260857 DOI: 10.1385/MO: 22: 4: 389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Juuti A, Louhimo J, Nordling S, Ristimäki A, Haglund C. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol. 2006;59:382-386. [PMID: 16467169 DOI: 10.1136/jcp.2005.026831] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
350 Aguilar EA, de la Haba-Rodríguez J, Macho A, Lucena C, Gómez A, Calzado M, Muñoz E. A study of the effect of salicylic acetic acid on a lymphocyte cell model of cellular activation and proliferation. Cancer Lett 2006;231:257-61. [PMID: 16011873 DOI: 10.1016/j.canlet.2005.02.014] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
351 Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005;86:347-63. [PMID: 16309541 DOI: 10.1111/j.0959-9673.2005.00447.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 116] [Article Influence: 8.3] [Reference Citation Analysis]
352 Klenke FM, Gebhard MM, Ewerbeck V, Abdollahi A, Huber PE, Sckell A. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice. BMC Cancer 2006;6:9. [PMID: 16409625 DOI: 10.1186/1471-2407-6-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
353 Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006;55:115-22. [PMID: 16118353 DOI: 10.1136/gut.2004.047100] [Cited by in Crossref: 602] [Cited by in F6Publishing: 560] [Article Influence: 37.6] [Reference Citation Analysis]
354 Patsos HA, Hicks DJ, Dobson RR, Greenhough A, Woodman N, Lane JD, Williams AC, Paraskeva C. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 2005;54:1741-50. [PMID: 16099783 DOI: 10.1136/gut.2005.073403] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 4.0] [Reference Citation Analysis]
355 Sales KJ, List T, Boddy SC, Williams AR, Anderson RA, Naor Z, Jabbour HN. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 2005;65:7707-16. [PMID: 16140938 DOI: 10.1158/0008-5472.CAN-05-0101] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 4.5] [Reference Citation Analysis]
356 Zhang C, Liu W, An J, Liu ZK. Effects of celecoxib on cell proliferation and expression of vascular endothelial growth factor in colonic cancer with hepatic metastasis. Shijie Huaren Xiaohua Zazhi 2005; 13(21): 2623-2626 [DOI: 10.11569/wcjd.v13.i21.2623] [Reference Citation Analysis]
357 Murata H, Yabe Y, Tsuji S, Tsujii M, Fu HY, Asahi K, Eguchi H, Kawano S, Hayashi N. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells. Dig Dis Sci 2005;50 Suppl 1:S70-5. [PMID: 16184424 DOI: 10.1007/s10620-005-2809-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
358 Yasuda H, Yamada M, Endo Y, Inoue K, Yoshiba M. Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorus. J Gastroenterol. 2005;40:690-697. [PMID: 16082585 DOI: 10.1007/s00535-005-1612-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
359 Cetin M, Buyukberber S, Demir M, Sari I, Sari I, Deniz K, Eser B, Altuntas F, Camci C, Oztürk A, Turgut B, Vural O, Unal A. Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival. Am J Hematol 2005;80:169-73. [PMID: 16247750 DOI: 10.1002/ajh.20460] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
360 Park MK, Kim MK, Kim JC, Sung YK. Pattern of apoptosis by NS398, a selective COX-2 inhibitor, in hepatocellular carcinoma cell lines. Cancer Res Treat 2005;37:313-7. [PMID: 19956533 DOI: 10.4143/crt.2005.37.5.313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
361 Wang XH, Li SB, Tong Q, Xie GJ, Wu QM. Effects of adenovirus-mediated human cyclooxygenase-2 antisense RNA on the growth of hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6110-6114 [PMID: 16273635 DOI: 10.3748/wjg.v11.i39.6110] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
362 Liu XJ, Wang BM, Yan XY, Liu WT, Lu ZS, Zhang J. Expression of COX-2 in Barrett's esophagus and esophageal adenocarcinoma and its significance. Shijie Huaren Xiaohua Zazhi 2005; 13(19): 2314-2317 [DOI: 10.11569/wcjd.v13.i19.2314] [Reference Citation Analysis]
363 Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T, Nagawa H. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J Gastroenterol 2005; 11(36): 5638-5643 [PMID: 16237757 DOI: 10.3748/wjg.v11.i36.5638] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
364 Bundred NJ, Barnes NL. Potential use of COX-2-aromatase inhibitor combinations in breast cancer. Br J Cancer 2005;93 Suppl 1:S10-5. [PMID: 16100520 DOI: 10.1038/sj.bjc.6602690] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
365 Yokoigawa N, Takeuchi N, Toda M, Inoue M, Kaibori M, Yanagida H, Tanaka H, Ogura T, Takada H, Okumura T, Kwon AH, Kamiyama Y, Nakada H. Enhanced production of interleukin 6 in peripheral blood monocytes stimulated with mucins secreted into the bloodstream. Clin Cancer Res 2005;11:6127-32. [PMID: 16144911 DOI: 10.1158/1078-0432.CCR-05-0292] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
366 Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005;294:914-23. [PMID: 16118381 DOI: 10.1001/jama.294.8.914] [Cited by in Crossref: 336] [Cited by in F6Publishing: 279] [Article Influence: 19.8] [Reference Citation Analysis]
367 Yoshida S, Ujiki M, Ding XZ, Pelham C, Talamonti MS, Bell RH Jr, Denham W, Adrian TE. Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer. 2005;4:27. [PMID: 16083499 DOI: 10.1186/1476-4598-4-27] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
368 Greene AK, Alwayn IP, Nose V, Flynn E, Sampson D, Zurakowski D, Folkman J, Puder M. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg 2005;242:140-6. [PMID: 15973112 DOI: 10.1097/01.sla.0000167847.53159.c1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
369 Kucknoor A, Mundodi V, Alderete JF. Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol 2005;7:887-97. [PMID: 15888089 DOI: 10.1111/j.1462-5822.2005.00522.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
370 Gustafsson AC, Kupershmidt I, Edlundh-Rose E, Greco G, Serafino A, Krasnowska EK, Lundeberg T, Bracci-Laudiero L, Romano MC, Parasassi T, Lundeberg J. Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro. BMC Cancer 2005;5:75. [PMID: 16001974 DOI: 10.1186/1471-2407-5-75] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
371 Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005;54:1034-43. [PMID: 15951555 DOI: 10.1136/gut.2004.053843] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 6.0] [Reference Citation Analysis]
372 Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005; 11(24): 3724-3728 [PMID: 15968728 DOI: 10.3748/wjg.v11.i24.3724] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
373 Tan KB, Putti TC. Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications. J Clin Pathol 2005;58:535-8. [PMID: 15858127 DOI: 10.1136/jcp.2004.021923] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
374 Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin Cancer Res 2005;11:4191-7. [PMID: 15930356 DOI: 10.1158/1078-0432.CCR-05-0108] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
375 Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K. A nuclear receptor ligand down-regulates cytosolic phospholipase A2 expression to reduce bile acid-induced cyclooxygenase 2 activity in cholangiocytes: implications of anticarcinogenic action of farnesoid X receptor agonists. Dig Dis Sci. 2005;50:514-524. [PMID: 15810635 DOI: 10.1007/s10620-005-2467-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
376 Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res 2005;7:R422-35. [PMID: 15987447 DOI: 10.1186/bcr1019] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 6.1] [Reference Citation Analysis]
377 Tanaka T, Delong PA, Amin K, Henry A, Kruklitis R, Kapoor V, Kaiser LR, Albelda SM. Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery. Ann Surg 2005;241:168-78. [PMID: 15622005 DOI: 10.1097/01.sla.0000149427.84712.d9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
378 Kobayashi H, Uetake H, Higuchi T, Enomoto M, Sugihara K. JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. BMC Cancer 2005;5:26. [PMID: 15743541 DOI: 10.1186/1471-2407-5-26] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
379 Casey MB, Zhang S, Jin L, Kajita S, Lloyd RV. Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions. Endocr Pathol 2004;15:107-16. [PMID: 15299197 DOI: 10.1385/ep:15:2:107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
380 Niho N, Mutoh M, Takahashi M, Tsutsumi K, Sugimura T, Wakabayashi K. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Proc Natl Acad Sci U S A 2005;102:2970-4. [PMID: 15710887 DOI: 10.1073/pnas.0500153102] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
381 Wang HM, Zhang GY. Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivoWorld J Gastroenterol 2005; 11(3): 340-343 [PMID: 15637740 DOI: 10.3748/wjg.v11.i3.340] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
382 Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A 2004;101:17825-30. [PMID: 15596715 DOI: 10.1073/pnas.0408340102] [Cited by in Crossref: 134] [Cited by in F6Publishing: 115] [Article Influence: 7.4] [Reference Citation Analysis]
383 Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, Lawrence E, Lutterbaugh J, Lu S, Willson JK. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci USA. 2004;101:17468-17473. [PMID: 15574495 DOI: 10.1073/pnas.0406142101] [Cited by in Crossref: 179] [Cited by in F6Publishing: 157] [Article Influence: 9.9] [Reference Citation Analysis]
384 Ozturk O, Saridogan E, Jauniaux E. Drug intervention in early pregnancy after assisted reproductive technology. Reprod Biomed Online 2004;9:452-65. [PMID: 15511349 DOI: 10.1016/s1472-6483(10)61283-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
385 Jang TJ. Expression of proteins related to prostag-landin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. Virchows Arch. 2004;445:564-571. [PMID: 15372235 DOI: 10.1007/s00428-004-1104-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
386 Wendum D, Masliah J, Trugnan G, Fléjou JF. Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch. 2004;445:327-333. [PMID: 15340847 DOI: 10.1007/s00428-004-1105-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.5] [Reference Citation Analysis]
387 Roche-Nagle G, Connolly EM, Eng M, Bouchier-Hayes DJ, Harmey JH. Antimetastatic activity of a cyclooxygenase-2 inhibitor. Br J Cancer 2004;91:359-65. [PMID: 15213717 DOI: 10.1038/sj.bjc.6601967] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
388 Wu AW, Gu J, Li ZF, Ji JF, Xu GW. COX-2 expression and tumor angiogenesis in colorectal cancer. World J Gastroenterol 2004; 10(16): 2323-2326 [PMID: 15285012 DOI: 10.3748/wjg.v10.i16.2323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
389 Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med. 2003;7:207-222. [PMID: 14594546 DOI: 10.1111/j.1582-4934.2003.tb00222.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 122] [Article Influence: 7.3] [Reference Citation Analysis]
390 Fu SL, Wu YL, Zhang YP, Qiao MM, Chen Y. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 2004; 10(13): 1971-1974 [PMID: 15222049 DOI: 10.3748/wjg.v10.i13.1971] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
391 Sanchez Alcaraz T, Kerkhofs P, Reichert M, Kettmann R, Willems L. Involvement of glutathione as a mechanism of indirect protection against spontaneous ex vivo apoptosis associated with bovine leukemia virus. J Virol 2004;78:6180-9. [PMID: 15163711 DOI: 10.1128/JVI.78.12.6180-6189.2004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
392 Sharma S, Batra RK, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter RM, Riedl K, Huang M, Dubinett SM. Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Hum Gene Ther 2003;14:1511-24. [PMID: 14577913 DOI: 10.1089/104303403322495025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
393 Rafiee P, Heidemann J, Ogawa H, Johnson NA, Fisher PJ, Li MS, Otterson MF, Johnson CP, Binion DG. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal. 2004;2:3. [PMID: 15175101 DOI: 10.1186/1478-811x-2-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
394 Mohammed NA, Abd El-Aleem SA, El-Hafiz HA, McMahon RF. Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol. 2004;57:350-354. [PMID: 15047734 DOI: 10.1136/jcp.2003.012120] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 3.4] [Reference Citation Analysis]
395 Vishwanatha JK, Swinney R, Banerjee AG. Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. Mol Cell Biochem 2003;248:67-75. [PMID: 12870656 DOI: 10.1023/a:1024153431272] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
396 Benitah SA, Valerón PF, Lacal JC. ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell. 2003;14:3041-3054. [PMID: 12857884 DOI: 10.1091/mbc.E03-01-0016] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
397 Kim SJ, Lee JH, Yoon JS, Mok JO, Kim YJ, Park HK, Kim CH, Byun DW, Suh KI, Yoo MH. Immunohistochemical expression of COX-2 in thyroid nodules. Korean J Intern Med 2003;18:225-9. [PMID: 14717230 DOI: 10.3904/kjim.2003.18.4.225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
398 Xie YL, Ma L. Apoptosis induced by mitomycin with sulindac on human gastric cancer cell SGC7901. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 542-545 [DOI: 10.11569/wcjd.v12.i3.542] [Reference Citation Analysis]
399 Yao M, Lam EC, Kelly CR, Zhou W, Wolfe MM. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer. 2004;90:712-719. [PMID: 14760389 DOI: 10.1038/sj.bjc.6601489] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 4.2] [Reference Citation Analysis]
400 Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 2004;90:423-9. [PMID: 14735188 DOI: 10.1038/sj.bjc.6601534] [Cited by in Crossref: 138] [Cited by in F6Publishing: 125] [Article Influence: 7.7] [Reference Citation Analysis]
401 Yoon JH, Canbay AE, Werneburg NW, Lee SP, Gores GJ. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis. Hepatology 2004;39:732-8. [PMID: 14999691 DOI: 10.1002/hep.20125] [Cited by in Crossref: 64] [Cited by in F6Publishing: 110] [Article Influence: 3.6] [Reference Citation Analysis]
402 Nathoo N, Barnett GH, Golubic M. The eicosanoid cascade: possible role in gliomas and meningiomas. J Clin Pathol 2004;57:6-13. [PMID: 14693827 DOI: 10.1136/jcp.57.1.6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
403 Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003;126:559-67. [PMID: 14611628 DOI: 10.1530/rep.0.1260559] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 5.7] [Reference Citation Analysis]
404 Howe LR, Dannenberg AJ. COX-2 inhibitors for the prevention of breast cancer. J Mammary Gland Biol Neoplasia 2003;8:31-43. [PMID: 14587862 DOI: 10.1023/a:1025731204719] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
405 Wang D, DuBois RN. Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci USA. 2004;101:415-416. [PMID: 14707264 DOI: 10.1073/pnas.0307640100] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
406 Jang TJ, Min SK, Bae JD, Jung KH, Lee JI, Kim JR, Ahn WS. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux. Gut 2004;53:27-33. [PMID: 14684572 DOI: 10.1136/gut.53.1.27] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
407 Okami J, Nakamori S, Hiraoka N, Tsujie M, Hayashi N, Yamamoto H, Fujiwara Y, Nagano H, Dono K, Umeshita K. Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor. Clin Exp Metastasis. 2003;20:577-584. [PMID: 14669788 DOI: 10.1023/A:1027319903359] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
408 Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9(12): 2642-2649 [PMID: 14669304 DOI: 10.3748/wjg.v9.i12.2642] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 79] [Article Influence: 4.6] [Reference Citation Analysis]
409 Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl 2:ii60-7. [PMID: 14532152 DOI: 10.1136/ard.62.suppl_2.ii60] [Cited by in Crossref: 65] [Cited by in F6Publishing: 100] [Article Influence: 3.4] [Reference Citation Analysis]
410 Smartt HJ, Elder DJ, Hicks DJ, Williams NA, Paraskeva C. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. Br J Cancer. 2003;89:1358-1365. [PMID: 14520472 DOI: 10.1038/sj.bjc.6601266] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
411 Banerjee AG, Liu J, Yuan Y, Gopalakrishnan VK, Johansson SL, Dinda AK, Gupta NP, Trevino L, Vishwanatha JK. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA. Mol Cancer 2003;2:34. [PMID: 14613585 DOI: 10.1186/1476-4598-2-34] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
412 Gallo O, Schiavone N, Papucci L, Sardi I, Magnelli L, Franchi A, Masini E, Capaccioli S. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. Am J Pathol. 2003;163:723-732. [PMID: 12875991 DOI: 10.1016/s0002-9440(10)63699-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
413 Tarnawski AS, Jones MK. Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med (Berl) 2003;81:627-36. [PMID: 13679997 DOI: 10.1007/s00109-003-0479-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 136] [Article Influence: 3.9] [Reference Citation Analysis]
414 Joo YE, Kim HS, Min SW, Lee WS, Park CH, Park CS, Choi SK, Rew JS, Kim SJ. Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer 2002;31:147-54. [PMID: 12622426 DOI: 10.1385/IJGC:31:1-3:147] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
415 Futagami S, Hiratsuka T, Tatsuguchi A, Suzuki K, Kusunoki M, Shinji Y, Shinoki K, Iizumi T, Akamatsu T, Nishigaki H, Wada K, Miyake K, Gudis K, Tsukui T, Sakamoto C. Monocyte chemoattractant protein 1 (MCP-1) released from Helicobacter pylori stimulated gastric epithelial cells induces cyclooxygenase 2 expression and activation in T cells. Gut 2003;52:1257-64. [PMID: 12912855 DOI: 10.1136/gut.52.9.1257] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
416 Cattaneo MG, Pola S, Dehò V, Sanguini AM, Vicentini LM. Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay. Br J Pharmacol. 2003;138:377-385. [PMID: 12540529 DOI: 10.1038/sj.bjp.0705051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
417 Charalambous MP, Maihöfner C, Bhambra U, Lightfoot T, Gooderham NJ. Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br J Cancer. 2003;88:1598-1604. [PMID: 12771929 DOI: 10.1038/sj.bjc.6600927] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
418 Sales KJ, Katz AA, Millar RP, Jabbour HN. Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells. Mol Hum Reprod 2002;8:1065-70. [PMID: 12468638 DOI: 10.1093/molehr/8.12.1065] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 1.5] [Reference Citation Analysis]
419 Caffrey AS, Patton WC, Corselli JU, Swensen RE, King A, Chan PJ. Cyclooxygenase (COX)-2 and granulosa cell apoptosis in vitro. J Assist Reprod Genet 2002;19:577-81. [PMID: 12503890 DOI: 10.1023/a:1021215216246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
420 Hashimoto K, Ethridge RT, Evers BM. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int J Gastrointest Cancer. 2002;32:7-22. [PMID: 12630765 DOI: 10.1385/ijgc:32:1:7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
421 Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol. 2003;162:793-801. [PMID: 12598314 DOI: 10.1016/s0002-9440(10)63876-x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 5.8] [Reference Citation Analysis]
422 Lew JI, Guo Y, Kim RK, Vargish L, Michelassi F, Arenas RB. Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive. J Gastrointest. Surg. 2002;6:563-568. [PMID: 12127122 DOI: 10.1016/s1091-255x(01)00042-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
423 Spizzo G, Gastl G, Wolf D, Gunsilius E, Steurer M, Fong D, Amberger A, Margreiter R, Obrist P. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer 2003;88:574-8. [PMID: 12592372 DOI: 10.1038/sj.bjc.6600741] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
424 Yang L, Yamagata N, Yadav R, Brandon S, Courtney RL, Morrow JD, Shyr Y, Boothby M, Joyce S, Carbone DP, Breyer RM. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J Clin Invest 2003;111:727-35. [PMID: 12618527 DOI: 10.1172/JCI16492] [Cited by in Crossref: 150] [Cited by in F6Publishing: 145] [Article Influence: 7.9] [Reference Citation Analysis]
425 Liu JP, Zhu ZH. Correlation of COX-2 expression and clinicopathological features of colorectal cancer. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 306-309 [DOI: 10.11569/wcjd.v11.i3.306] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
426 Jang TJ, Jung HG, Jung KH, O MK. Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours. Int J Exp Pathol 2002;83:173-82. [PMID: 12485462 DOI: 10.1046/j.1365-2613.2002.00228.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
427 Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 2003;37:674-85. [PMID: 12601365 DOI: 10.1053/jhep.2003.50068] [Cited by in Crossref: 152] [Cited by in F6Publishing: 123] [Article Influence: 8.0] [Reference Citation Analysis]
428 Amano H, Hayashi I, Endo H, Kitasato H, Yamashina S, Maruyama T, Kobayashi M, Satoh K, Narita M, Sugimoto Y. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med. 2003;197:221-232. [PMID: 12538661 DOI: 10.1084/jem.20021408] [Cited by in Crossref: 235] [Cited by in F6Publishing: 220] [Article Influence: 12.4] [Reference Citation Analysis]
429 Inaba T, Sano H, Kawahito Y, Hla T, Akita K, Toda M, Yamashina I, Inoue M, Nakada H. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc Natl Acad Sci U S A 2003;100:2736-41. [PMID: 12598658 DOI: 10.1073/pnas.0435410100] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
430 Natarajan K, Mori N, Artemov D, Bhujwalla ZM. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia 2002;4:409-16. [PMID: 12192599 DOI: 10.1038/sj.neo.7900252] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
431 Amano H, Haysahi I, Yoshida S, Yoshimura H, Majima M. Cyclooxygenase-2 and adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Hum Cell. 2002;15:13-24. [PMID: 12126060 DOI: 10.1111/j.1749-0774.2002.tb00095.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
432 Wenger FA, Kilian M, Bisevac M, Khodadayan C, von Seebach M, Schimke I, Guski H, Müller JM. Effects of Celebrex and Zyflo on liver metastasis and lipidperoxidation in pancreatic cancer in Syrian hamsters. Clin Exp Metastasis 2002;19:681-7. [PMID: 12553373 DOI: 10.1023/a:1021387826867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
433 Lara-Pezzi E, Gómez-Gaviro MV, Gálvez BG, Mira E, Iñiguez MA, Fresno M, Martínez-A C, Arroyo AG, López-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 2002;110:1831-8. [PMID: 12488433 DOI: 10.1172/JCI15887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 76] [Article Influence: 0.2] [Reference Citation Analysis]
434 Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, Fresno M, Martinez AC, Arroyo AG, Lopez-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest. 2002;110:1831-1838. [PMID: 12488433 DOI: 10.1172/jci200215887] [Cited by in Crossref: 135] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
435 Scholl SM, Michaelis S, McDermott R. Gene Therapy Applications to Cancer Treatment. J Biomed Biotechnol. 2003;2003:35-47. [PMID: 12686721 DOI: 10.1155/s1110724303209037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
436 Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix. Mol Biotechnol. 2002;21:85-90. [PMID: 11989661 DOI: 10.1385/mb:21:1:085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
437 Ferrandina G, Lauriola L, Zannoni GF, Distefano MG, Legge F, Salutari V, Gessi M, Maggiano N, Scambia G, Ranelletti FO. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications. Br J Cancer 2002;87:1145-52. [PMID: 12402155 DOI: 10.1038/sj.bjc.6600578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
438 Konno H, Baba M, Shoji T, Ohta M, Suzuki S, Nakamura S. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin Exp Metastasis. 2002;19:527-534. [PMID: 12405290 DOI: 10.1023/a:1020392309715] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
439 Qiu DK, Ma X, Peng YS, Chen XY. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol 2002; 8(5): 815-817 [PMID: 12378621 DOI: 10.3748/wjg.v8.i5.815] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
440 Kern MA, Schubert D, Sahi D, Schöneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 2002;36:885-94. [PMID: 12297835 DOI: 10.1053/jhep.2002.36125] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 5.1] [Reference Citation Analysis]
441 Yao M, Song DH, Rana B, Wolfe MM. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br J Cancer 2002;87:574-9. [PMID: 12189559 DOI: 10.1038/sj.bjc.6600495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
442 Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci U S A 2002;99:12483-8. [PMID: 12221288 DOI: 10.1073/pnas.192323799] [Cited by in Crossref: 194] [Cited by in F6Publishing: 172] [Article Influence: 9.7] [Reference Citation Analysis]
443 Kim ES, Herbst RS. Angiogenesis inhibitors in lung cancer. Curr Oncol Rep 2002;4:325-33. [PMID: 12044242 DOI: 10.1007/s11912-002-0008-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
444 Connolly EM, Harmey JH, O'Grady T, Foley D, Roche-Nagle G, Kay E, Bouchier-Hayes DJ. Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer. Br J Cancer. 2002;87:231-237. [PMID: 12107848 DOI: 10.1038/sj.bjc.6600462] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
445 Roman CD, Morrow J, Whitehead R, Beauchamp RD. Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-beta(1) in immortalized mouse colonocytes expressing oncogenic Ras. J Gastrointest Surg. 2002;6:304-309. [PMID: 12022979 DOI: 10.1016/s1091-255x(01)00041-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
446 Seki S, Kitada T, Sakaguchi H, Hirohashi K, Kinoshita H. Cyclooxygenase-2 expression in the adenoma-carcinoma sequence of human gallbladder. Am J Gastroenterol 2002;97:2146-7. [PMID: 12190199 DOI: 10.1111/j.1572-0241.2002.05943.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
447 Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. Cyclooxygenase-2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002;55:429-434. [PMID: 12037025 DOI: 10.1136/jcp.55.6.429] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 9.1] [Reference Citation Analysis]
448 Minagawa A, Otani Y, Kubota T, Wada N, Furukawa T, Kumai K, Kameyama K, Okada Y, Fujii M, Yano M, Sato T, Ito A, Kitajima M. The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice. Jpn J Cancer Res 2001;92:1322-8. [PMID: 11749698 DOI: 10.1111/j.1349-7006.2001.tb02156.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
449 Ghosh AK, Hirasawa N, Ohtsu H, Watanabe T, Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002;195:973-82. [PMID: 11956288 DOI: 10.1084/jem.20011782] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 4.2] [Reference Citation Analysis]
450 You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL, MacDougald OA, Brown AM, Evan G, Kitajewski J, Wang CY. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 2002;157:429-40. [PMID: 11980918 DOI: 10.1083/jcb.200201110] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 6.8] [Reference Citation Analysis]
451 Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, Maeshima A, Yamada T, Matsuno Y, Fukayama M, Yokota J, Hirohashi S. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol 2002;160:1129-41. [PMID: 11891209 DOI: 10.1016/s0002-9440(10)64933-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
452 Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54. [PMID: 11900251 DOI: 10.1038/35094059] [Cited by in Crossref: 1435] [Cited by in F6Publishing: 1329] [Article Influence: 71.8] [Reference Citation Analysis]
453 Denkert C, Köbel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002;160:893-903. [PMID: 11891188 DOI: 10.1016/S0002-9440(10)64912-7] [Cited by in Crossref: 141] [Cited by in F6Publishing: 129] [Article Influence: 7.1] [Reference Citation Analysis]
454 Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2000;2:483-90. [PMID: 11228540 DOI: 10.1038/sj.neo.7900119] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 4.5] [Reference Citation Analysis]
455 Zhang Z, Sheng H, Shao J, Beauchamp RD, DuBois RN. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia 2000;2:523-30. [PMID: 11228545 DOI: 10.1038/sj.neo.7900117] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
456 Fantappiè O, Masini E, Sardi I, Raimondi L, Bani D, Solazzo M, Vannacci A, Mazzanti R. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology 2002;35:843-52. [PMID: 11915030 DOI: 10.1053/jhep.2002.32469] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
457 Bakhle YS. COX-2 and cancer: a new approach to an old problem. Br J Pharmacol. 2001;134:1137-1150. [PMID: 11704632 DOI: 10.1038/sj.bjp.0704365] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 4.0] [Reference Citation Analysis]
458 Husain SS, Szabo IL, Tamawski AS. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol 2002;97:542-53. [PMID: 11922545 DOI: 10.1111/j.1572-0241.2002.05528.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
459 Wang X, Lan M, Wu HP, Shi YQ, Lu J, Ding J, Wu KC, Jin JP, Fan DM. Direct effect of croton oil on intestinal epithelial cells and colonic smooth muscle cells. World J Gastroenterol 2002; 8(1): 103-107 [PMID: 11833082 DOI: 10.3748/wjg.v8.i1.103] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
460 Callejas NA, Casado M, Boscá L, Martín-Sanz P. Absence of nuclear factor kappaB inhibition by NSAIDs in hepatocytes. Hepatology 2002;35:341-8. [PMID: 11826407 DOI: 10.1053/jhep.2002.31163] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
461 Ghosh AK, Hirasawa N, Ohuchi K. Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors. Br J Pharmacol 2001;134:1419-28. [PMID: 11724747 DOI: 10.1038/sj.bjp.0704372] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
462 Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, Prescott SM. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest. 2001;108:1657-1665. [PMID: 11733561 DOI: 10.1172/jci12973] [Cited by in Crossref: 257] [Cited by in F6Publishing: 304] [Article Influence: 12.9] [Reference Citation Analysis]
463 Jones MK, Szabó IL, Kawanaka H, Husain SS, Tarnawski AS. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB J 2002;16:264-6. [PMID: 11772947 DOI: 10.1096/fj.01-0589fje] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 2.9] [Reference Citation Analysis]
464 Wu YL, Sun B, Zhang XJ, Wang SN, He HY, Qiao MM, Zhong J, Xu JY. Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells. World J Gastroenterol 2001; 7(6): 796-800 [PMID: 11854904 DOI: 10.3748/wjg.v7.i6.796] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 58] [Article Influence: 2.0] [Reference Citation Analysis]
465 Stockton RA, Jacobson BS. Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts. Mol Biol Cell 2001;12:1937-56. [PMID: 11451994 DOI: 10.1091/mbc.12.7.1937] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
466 Viñals F, Pouysségur J. Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 2001;21:7218-30. [PMID: 11585905 DOI: 10.1128/MCB.21.21.7218-7230.2001] [Cited by in Crossref: 149] [Cited by in F6Publishing: 139] [Article Influence: 7.1] [Reference Citation Analysis]
467 Umemoto M, Yokoyama Y, Sato S, Tsuchida S, Al-Mulla F, Saito Y. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 2001;85:1032-6. [PMID: 11592776 DOI: 10.1054/bjoc.2001.2034] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
468 Shappell SB, Manning S, Boeglin WE, Guan YF, Roberts RL, Davis L, Olson SJ, Jack GS, Coffey CS, Wheeler TM, Breyer MD, Brash AR. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia 2001;3:287-303. [PMID: 11571629 DOI: 10.1038/sj.neo.7900166] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
469 O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001;85:473-483. [PMID: 11506482 DOI: 10.1054/bjoc.2001.1943] [Cited by in Crossref: 355] [Cited by in F6Publishing: 331] [Article Influence: 16.9] [Reference Citation Analysis]
470 Rudnick DA, Perlmutter DH, Muglia LJ. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 2001;98:8885-90. [PMID: 11447268 DOI: 10.1073/pnas.151217998] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 4.9] [Reference Citation Analysis]
471 Heslin MJ, Yan J, Johnson MR, Weiss H, Diasio RB, Urist MM. Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg. 2001;233:786-792. [PMID: 11371737 DOI: 10.1097/00000658-200106000-00008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.3] [Reference Citation Analysis]
472 Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3:53-61. [PMID: 11326316 DOI: 10.1038/sj.neo.7900127] [Cited by in Crossref: 204] [Cited by in F6Publishing: 193] [Article Influence: 9.7] [Reference Citation Analysis]
473 Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, Millar RP, Jabbour HN. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001;86:2243-9. [PMID: 11344234 DOI: 10.1210/jcem.86.5.7442] [Cited by in Crossref: 69] [Cited by in F6Publishing: 84] [Article Influence: 3.3] [Reference Citation Analysis]
474 Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, Pagano JS. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A 2001;98:6905-10. [PMID: 11381123 DOI: 10.1073/pnas.121016998] [Cited by in Crossref: 185] [Cited by in F6Publishing: 181] [Article Influence: 8.8] [Reference Citation Analysis]
475 Gupta RA, Tan J, Krause WF, Geraci MW, Willson TM, Dey SK, DuBois RN. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci USA. 2000;97:13275-13280. [PMID: 11087869 DOI: 10.1073/pnas.97.24.13275] [Cited by in Crossref: 303] [Cited by in F6Publishing: 267] [Article Influence: 14.4] [Reference Citation Analysis]
476 Hernández GL, Volpert OV, Iñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M, Redondo JM. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001;193:607-20. [PMID: 11238591 DOI: 10.1084/jem.193.5.607] [Cited by in Crossref: 317] [Cited by in F6Publishing: 289] [Article Influence: 15.1] [Reference Citation Analysis]
477 Wijnhoven BP, Tilanus HW, Dinjens WN. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001;233:322-37. [PMID: 11224619 DOI: 10.1097/00000658-200103000-00005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
478 Leung WK, To KF, Ng YP, Lee TL, Lau JY, Chan FK, Ng EK, Chung SC, Sung JJ. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br J Cancer 2001;84:335-9. [PMID: 11161397 DOI: 10.1054/bjoc.2000.1607] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 4.0] [Reference Citation Analysis]
479 Hull MA, Fenwick SW, Chapple KS, Scott N, Toogood GJ, Lodge JP. Cyclooxygenase-2 expression in colorectal cancer liver metastasis. Clin Exp Metastasis. 2000;18:21-27. [PMID: 11206834 DOI: 10.1023/a:1026553605636] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
480 Tominaga M, Migita K, Sano H, Fukui W, Kohno M, Tsubouchi Y, Honda S, Fukuda T, Nakamura H, Yamasaki S, Kawabe Y, Kawakami A, Eguchi K. Expression of cyclooxygenase-1 (COX-1) in labial salivary glands of Sjögren's syndrome. Clin Exp Immunol 2000;122:459-63. [PMID: 11122255 DOI: 10.1046/j.1365-2249.2000.01302.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
481 Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A. Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 2000;20:8571-9. [PMID: 11046152 DOI: 10.1128/MCB.20.22.8571-8579.2000] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 2.8] [Reference Citation Analysis]
482 Nakatsugi S, Ohta T, Kawamori T, Mutoh M, Tanigawa T, Watanabe K, Sugie S, Sugimura T, Wakabayashi K. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats. Jpn J Cancer Res 2000;91:886-92. [PMID: 11011115 DOI: 10.1111/j.1349-7006.2000.tb01030.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 3.6] [Reference Citation Analysis]
483 Koch AE. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 2000;59 Suppl 1:i65-71. [PMID: 11053092 DOI: 10.1136/ard.59.suppl_1.i65] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 2.8] [Reference Citation Analysis]
484 Arber N, DuBois RN. Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer. Curr Gastroenterol Rep. 1999;1:441-448. [PMID: 10980984 DOI: 10.1007/s11894-999-0027-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
485 Evans JJ, Lee JH, Park YS, Jeun S, Harwalkar JA, Safayhi H, Golubic M. Future Treatment Modalities for Meningiomas. Neurosurgery Clinics of North America 2000;11:717-33. [DOI: 10.1016/s1042-3680(18)30096-2] [Reference Citation Analysis]
486 Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 2000;105:1589-1594. [PMID: 10841517 DOI: 10.1172/jci9621] [Cited by in Crossref: 494] [Cited by in F6Publishing: 460] [Article Influence: 22.5] [Reference Citation Analysis]
487 Prescott SM. Is cyclooxygenase-2 the alpha and the omega in cancer. J Clin Invest. 2000;105:1511-1513. [PMID: 10841506 DOI: 10.1172/jci10241] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 2.9] [Reference Citation Analysis]
488 Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL, Beauchamp RD. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia. 1999;1:508-517. [PMID: 10935498 DOI: 10.1038/sj.neo.7900051] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
489 Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, Levine AC. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis. 1999;17:687-694. [PMID: 10919714 DOI: 10.1023/a:1006728119549] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 5.5] [Reference Citation Analysis]
490 Kömhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, Koch MO, Shappell SB, Breyer MD. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 2000;157:29-35. [PMID: 10880372 DOI: 10.1016/S0002-9440(10)64513-0] [Cited by in Crossref: 110] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
491 Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y, Nagawa H. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer. 2000;83:324-328. [PMID: 10917546 DOI: 10.1054/bjoc.2000.1270] [Cited by in Crossref: 154] [Cited by in F6Publishing: 142] [Article Influence: 7.0] [Reference Citation Analysis]
492 Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol. 2000;130:641-649. [PMID: 10821793 DOI: 10.1038/sj.bjp.0703327] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 6.4] [Reference Citation Analysis]
493 Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S, Kishida T, Fukuda Y, Yamanaka N, Kobayashi M. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000;46:782-9. [PMID: 10807888 DOI: 10.1136/gut.46.6.782] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]
494 Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 2000;129:823-34. [PMID: 10696077 DOI: 10.1038/sj.bjp.0703149] [Cited by in Crossref: 261] [Cited by in F6Publishing: 238] [Article Influence: 11.9] [Reference Citation Analysis]
495 Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL, Hull MA. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000;156:545-53. [PMID: 10666384 DOI: 10.1016/S0002-9440(10)64759-1] [Cited by in Crossref: 144] [Cited by in F6Publishing: 132] [Article Influence: 6.5] [Reference Citation Analysis]
496 Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res. 1999;90:1338-1343. [PMID: 10665651 DOI: 10.1111/j.1349-7006.1999.tb00717.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
497 Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res. 1999;90:1152-1162. [PMID: 10595745 DOI: 10.1111/j.1349-7006.1999.tb00690.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 3.2] [Reference Citation Analysis]
498 Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer. 1999;81:1274-1279. [PMID: 10604722 DOI: 10.1038/sj.bjc.6694262] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 4.0] [Reference Citation Analysis]
499 Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999;5:1418-23. [PMID: 10581086 DOI: 10.1038/70995] [Cited by in Crossref: 606] [Cited by in F6Publishing: 538] [Article Influence: 26.3] [Reference Citation Analysis]
500 Schönbeck U, Sukhova GK, Graber P, Coulter S, Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999;155:1281-91. [PMID: 10514410 DOI: 10.1016/S0002-9440(10)65230-3] [Cited by in Crossref: 277] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
501 Dimberg J, Samuelsson A, Hugander A, Söderkvist P. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 1999;45:730-2. [PMID: 10517910 DOI: 10.1136/gut.45.5.730] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 3.9] [Reference Citation Analysis]
502 Hull MA, Thomson JL, Hawkey CJ. Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells. Gut 1999;45:529-36. [PMID: 10486360 DOI: 10.1136/gut.45.4.529] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
503 Castaño E, Dalmau M, Barragán M, Pueyo G, Bartrons R, Gil J. Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells. Br J Cancer 1999;81:294-9. [PMID: 10496355 DOI: 10.1038/sj.bjc.6690690] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
504 Shiff SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 1999;190:445-50. [PMID: 10449515 DOI: 10.1084/jem.190.4.445] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 4.8] [Reference Citation Analysis]
505 Zhang X, Morham SG, Langenbach R, Young DA. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med. 1999;190:451-459. [PMID: 10449516 DOI: 10.1084/jem.190.4.451] [Cited by in Crossref: 189] [Cited by in F6Publishing: 183] [Article Influence: 8.2] [Reference Citation Analysis]
506 Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 1999;13:1561-74. [PMID: 10385625 DOI: 10.1101/gad.13.12.1561] [Cited by in Crossref: 425] [Cited by in F6Publishing: 377] [Article Influence: 18.5] [Reference Citation Analysis]
507 Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori H. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Jpn J Cancer Res. 1999;90:406-412. [PMID: 10363578 DOI: 10.1111/j.1349-7006.1999.tb00762.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]